CN105732620B - Indolizidine iminosugar and its precursor compound and their preparation method and application - Google Patents
Indolizidine iminosugar and its precursor compound and their preparation method and application Download PDFInfo
- Publication number
- CN105732620B CN105732620B CN201610202477.7A CN201610202477A CN105732620B CN 105732620 B CN105732620 B CN 105732620B CN 201610202477 A CN201610202477 A CN 201610202477A CN 105732620 B CN105732620 B CN 105732620B
- Authority
- CN
- China
- Prior art keywords
- reaction
- added
- formula
- iminosugar
- xiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to the synthesis fields of natural products, Indolizidine iminosugar and its precursor compound and their preparation method and application are disclosed, iminosugar of the invention is the compound or its pharmaceutically acceptable salt of structure shown in Formulas I: precursor compound is the compound or its pharmaceutically acceptable salt of structure shown in Formula XIV.Indolizidine iminosugar provided by the invention or its pharmaceutically acceptable salt have the activity for inhibiting glycosidase and can be used in treating diabetes.Moreover, the precursor compound of Indolizidine iminosugar provided by the invention also has the active effect for inhibiting glycosidase.
Description
Technical field
The present invention relates to the synthesis fields of natural products, and in particular, to a kind of Indolizidine iminosugar and should
The preparation of the precursor compound of Indolizidine iminosugar and the Indolizidine iminosugar and its precursor compound
Method and application.
Background technique
Glycosidase takes part in many important bioprocesses related with glycoconjugates, digestion, sugared egg such as enteral
The glycoconjugates metabolism etc. of white synthesis and decomposition, lysosome, plays key player in life entity, close with many diseases
Cut phase is closed.
Iminosugar, also known as polyhydroxylated alkaloid, azasugar, imines sugar etc. are effective inhibitor of glycosidase, disease-resistant
Malicious, antitumor, treatment diabetes etc. have important pharmacological activity.
It is developed to drug there are many iminosugar and lists (such as NBDNJ, Miglitol, Miglustat etc.).
In iminosugar, Indolizidine class compound has consequence, many Indolizidine class imino groups
Sugar has good bioactivity [such as (-)-swainsonine, (-)-castanospermine etc.], there is huge answer
Use prospect.Due to the good nature that Indolizidine class iminosugar is shown, the Indolizidine with novel structure is found
Alkaloid becomes field concerned by people.
STEVIA REBAUDIANA alkali is the Indolizidine class iminosugar with alkyl side chain found for the first time in recent years, novel
Structure causes the research interest of people.In recent years, in order to further study the chemistry and bioactivity of STEVIA REBAUDIANA alkali, about sweet tea
The research of leaf chrysanthemum alkali appears in the newspapers repeatly.And the bioactivity research for developing a kind of convenient, general synthetic method and system becomes
The emphasis of this field researcher concern.
Summary of the invention
Inhibit glycosidase activity the object of the present invention is to provide a kind of new having and can be used in treating the change of diabetes
Close object and its precursor compound and their pharmaceutically acceptable salts.
To achieve the goals above, in a first aspect, the present invention provides a kind of Indolizidine iminosugar, the iminosugar
For the compound or its pharmaceutically acceptable salt of structure shown in Formulas I:
Wherein, R1For hydrogen atom or methylol, R2Linear chain or branched chain saturated alkyl, allyl, benzyl selected from C1-C12 and
At least one of the benzyl that hydrogen atom on phenyl ring is replaced by methoxyl group or halogen;1, the spatial configuration of 2,3,5 and 8a carbon
It is each independently R or S;And work as R1For methylol, R2When for methyl, the iminosugar does not include 1,2,3,5 and 8a carbon
The compound of respectively following spatial configuration: (1R, 2R, 3R, 5R, 8aR), (1R, 2S, 3R, 5R, 8aR), (1R, 2S, 3R, 5S,
8aR), (1S, 2R, 3S, 5S, 8aS) and (1S, 2R, 3S, 5R, 8aS).
Second aspect, the present invention provide the precursor compound of aforementioned iminosugar, which is knot shown in Formula XIV
The compound of structure or its pharmaceutically acceptable salt:
Wherein, R3And R8It is each independently selected from the linear chain or branched chain saturated alkyl, allyl, propylidene base, acetyl of C1-C12
The benzyl that hydrogen atom on base, benzoyl, benzyl and phenyl ring is replaced by methoxyl group or halogen;
R7For hydrogen atom or R7For linear chain or branched chain saturated alkyl, allyl, acetyl group, the benzene of oxygen atom and C1-C12
The methylol that at least one of the benzyl that hydrogen atom on formoxyl, benzyl and phenyl ring is replaced by methoxyl group or halogen is connected;
R2Hydrogen atom on linear chain or branched chain saturated alkyl, allyl, benzyl and phenyl ring selected from C1-C12 is by methoxyl group
Or at least one of the benzyl that halogen replaces;
The spatial configuration of 1,2,3,5 and 8a carbon in the compound of structure shown in Formula XIV respectively in Formulas I 1,2,3,
5 is identical with the spatial configuration of 8a carbon;And work as R7For benzyloxymethyl, R2When for methyl, the precursor compound do not include 1,2,
3,5 and 8a carbon is respectively the compound of following spatial configuration: (1S, 2R, 3S, 5S, 8aS) and (1S, 2R, 3S, 5R, 8aS).
The third aspect, the present invention provides the preparation method of aforementioned Indolizidine iminosugar, this method comprises: in acidity
Under the conditions of, in the presence of a catalyst, present invention precursor compound above-mentioned is subjected to hydrogenation;Or
In the presence of a lewis acid, present invention precursor compound above-mentioned is subjected to deprotection reaction.
Fourth aspect, the present invention provide a kind of method for preparing present invention precursor compound above-mentioned, this method include with
Lower step:
(1) nitrone shown in Formula II is reacted with Grignard Reagent, obtains azanol shown in formula III;
(2) azanol shown in the formula III is subjected to reduction reaction, obtains amine shown in formula IV;
(3) under alkaline condition, amine shown in the formula IV is subjected to protection reaction, obtains Formula V compound represented;
(4) the Formula V compound represented is subjected to oxidation reaction, obtains ketone shown in Formula IV;
(5) ketone shown in the Formula IV is subjected to reduction reaction, obtains alcohol shown in Formula VII;
(6) alcohol shown in the Formula VII is subjected to sulfonating reaction, obtains Formula VIII compound represented;
(7) Formula VIII compound represented is subjected to deprotection reaction, obtains amine shown in Formula IX;
(8) amine shown in Formula IX is subjected to ring closure reaction, obtains precursor compound shown in Formula XIV;
Wherein, R3、R8And R7Definition it is identical as present invention definition above-mentioned;
R in Formula V-Formula VIII4Correspondence is identical, and R4Selected from tertbutyloxycarbonyl, fluorenylmethoxycarbonyl, acetyl group, allyl, benzyl
At least one of benzyloxycarbonyl group obtained by hydrogen atom in oxygen carbonyl and phenyl ring is replaced by methoxyl group or halogen;
R in Formula VIII and Formula IX5It is identical, and R5Selected from selected from mesyl, trifyl, benzenesulfonyl, to first
At least one of benzenesulfonyl obtained by hydrogen atom on benzenesulfonyl and phenyl ring is replaced by methoxyl group or halogen;
The spatial configuration of 1,2 and 3 carbon in Formula II-Formula IX respectively in the compound of structure shown in Formula XIV 1,2 and
The spatial configuration of 3 carbon corresponds to identical;The spatial configuration of 4 carbon in formula III-Formula IX is identical, is R or S configuration;Formula VII-formula
The spatial configuration of 8 carbon in IX is identical, is R or S configuration.
5th aspect, the present invention provide a kind of method for preparing present invention precursor compound above-mentioned, this method include with
Lower step:
(1) nitrone shown in Formula II is reacted with Grignard Reagent, obtains azanol shown in formula III;
(2) azanol shown in the formula III is subjected to reduction reaction, obtains amine shown in formula IV;
(3) under alkaline condition, amine shown in the formula IV is subjected to protection reaction, obtains Formula V compound represented;
(4) Formula V compound represented is subjected to oxidation reaction, obtains aldehyde shown in Formula X;
(5) aldehyde shown in Formula X is reacted with Grignard Reagent, obtains alcohol shown in Formula XI;
(6) alcohol shown in Formula XI is subjected to sulfonating reaction, obtains Formula XII compound represented;
(7) Formula XII compound represented is subjected to deprotection reaction, obtains amine shown in Formula XIII;
(8) amine shown in Formula XIII is subjected to ring closure reaction, obtains precursor compound shown in Formula XIV;
Wherein, R3、R8And R7Definition it is identical as present invention definition above-mentioned;
R in Formula V and Formula X-Formula XII4Correspondence is identical, and R4Definition it is identical as present invention definition above-mentioned;
R in Formula XII-Formula XIII5It is identical, and R5Definition it is identical as present invention definition above-mentioned;
R in Formula XI and Formula XIII6It is identical, and R6Linear chain or branched chain saturated alkyl, allyl, propylidene selected from C1-C12
At least one of the benzyl that hydrogen atom on base, acetyl group, benzoyl, benzyl and phenyl ring is replaced by methoxyl group or halogen;
The spatial configuration change with structure shown in Formula XIV respectively of 1,2 and 3 carbon in Formula II-Formula V and Formula X-Formula XIII
The spatial configuration of 1,2 and 3 carbon in conjunction object corresponds to identical;The three-dimensional structure of 4 carbon in formula III-Formula V and Formula X-Formula XIII
Type is identical, is R or S configuration;The spatial configuration of 8 carbon in Formula XI-Formula XIII is identical, is R or S configuration.
6th aspect, the present invention provide the precursor compound or its medicine of iminosugar above-mentioned or iminosugar above-mentioned
Application of the acceptable salt in the drug that preparation inhibits glycosidase activity on.
7th aspect, the present invention provide iminosugar above-mentioned or its pharmaceutically acceptable salt preparation prevention and/
Or the application in treatment diabetes, prevention and/or treatment gaucher's disease, prevention and/or treatment tumour and antiviral drug.
Indolizidine iminosugar provided by the invention or its pharmaceutically acceptable salt have the work for inhibiting glycosidase
Property and can be used in treat diabetes.Moreover, the precursor compound of Indolizidine iminosugar provided by the invention also has
Inhibit the active effect of glycosidase.
The method provided by the invention for preparing the Indolizidine iminosugar and its precursor compound is at low cost
Honest and clean advantage.
Other features and advantages of the present invention will the following detailed description will be given in the detailed implementation section.
Specific embodiment
Detailed description of the preferred embodiments below.It should be understood that described herein specific
Embodiment is merely to illustrate and explain the present invention, and is not intended to restrict the invention.
First aspect, the present invention provides a kind of Indolizidine iminosugar, which is structure shown in Formulas I
Compound or its pharmaceutically acceptable salt:
Wherein, R1For hydrogen atom or methylol, R2Linear chain or branched chain saturated alkyl, allyl, benzyl selected from C1-C12 and
At least one of the benzyl that hydrogen atom on phenyl ring is replaced by methoxyl group or halogen;1, the spatial configuration of 2,3,5 and 8a carbon
It is each independently R or S;And work as R1For methylol, R2When for methyl, the iminosugar does not include 1,2,3,5 and 8a carbon
The compound of respectively following spatial configuration: (1R, 2R, 3R, 5R, 8aR), (1R, 2S, 3R, 5R, 8aR), (1R, 2S, 3R, 5S,
8aR), (1S, 2R, 3S, 5S, 8aS) and (1S, 2R, 3S, 5R, 8aS).
The linear chain or branched chain saturated alkyl of the C1-C12 includes methyl, ethyl, n-propyl, isopropyl, normal-butyl, isobutyl
Base, tert-butyl, n-pentyl, isopentyl, n-hexyl, cyclopropyl, methylcyclopropyl groups, ethyl cyclopropyl, cyclopenta, methyl ring penta
At least one of base, cyclohexyl, n-heptyl, n-octyl, n-nonyl, positive decyl, n-undecane base and dodecyl.
The halogen includes at least one of fluorine, chlorine, bromine and iodine.
Preferably, the iminosugar is selected from least one of following compound or its pharmaceutically acceptable salt:
Second aspect, the present invention provides the precursor compound of aforementioned iminosugar, which is shown in Formula XIV
The compound of structure or its pharmaceutically acceptable salt:
Wherein, R3And R8It is each independently selected from the linear chain or branched chain saturated alkyl, allyl, propylidene base, acetyl of C1-C12
The benzyl that hydrogen atom on base, benzoyl, benzyl and phenyl ring is replaced by methoxyl group or halogen;
R7For hydrogen atom or R7For linear chain or branched chain saturated alkyl, allyl, acetyl group, the benzene of oxygen atom and C1-C12
The methylol that at least one of the benzyl that hydrogen atom on formoxyl, benzyl and phenyl ring is replaced by methoxyl group or halogen is connected;
R2Hydrogen atom on linear chain or branched chain saturated alkyl, allyl, benzyl and phenyl ring selected from C1-C12 is by methoxyl group
Or at least one of the benzyl that halogen replaces;
The spatial configuration of 1,2,3,5 and 8a carbon in the compound of structure shown in Formula XIV respectively in Formulas I 1,2,3,
5 is identical with the spatial configuration of 8a carbon;And work as R7For benzyloxymethyl, R2When for methyl, the precursor compound do not include 1,2,
3,5 and 8a carbon is respectively the compound of following spatial configuration: (1S, 2R, 3S, 5S, 8aS) and (1S, 2R, 3S, 5R, 8aS).
The third aspect, the present invention provides the preparation methods of aforementioned Indolizidine iminosugar, this method comprises: in acid
Property under the conditions of, in the presence of a catalyst, present invention precursor compound above-mentioned is subjected to hydrogenation;Or
In the presence of a lewis acid, present invention precursor compound above-mentioned is subjected to deprotection reaction.
In the preparation method of the Indolizidine iminosugar, the catalyst includes but are not limited to palladium carbon, palladium
Black, palladium dydroxide, palladium chloride, platinum oxide, platinum black, ruthenic chloride and Wilkinson catalyst.
The hydrogenation preferably carries out in the presence of hydrogen source, and the hydrogen source includes but are not limited to hydrogen, ammonium formate, connection
Imido, cyclohexene and cyclohexadiene.
The acid condition preferably carries out in the presence of organic acid or inorganic acid, wherein the organic acid includes formic acid, second
At least one of acid, p-methyl benzenesulfonic acid and benzoic acid;The inorganic acid include in sulfuric acid, hydrochloric acid, phosphoric acid and perchloric acid extremely
Few one kind.
The lewis acid is preferably selected from boron trifluoride, boron chloride, Boron tribromide, Iodotrimethylsilane and titanium tetrachloride
At least one of.
The preparation method of the Indolizidine iminosugar preferably carries out in the presence of solvent, and the solvent includes first
Alcohol, ethyl alcohol, acetonitrile, tetrahydrofuran, toluene, acetone, methylene chloride, chloroform, 1,2- dichloroethanes, N,N-dimethylformamide and
At least one of dimethyl sulfoxide.
The condition of the deprotection reaction includes: that temperature is 0-100 DEG C;Time is 0.1-24 hours, and preferably 2-3 is small
When.
The condition of the hydrogenation can be identical or different with the condition of the deprotection reaction;Preferably, the hydrogen
It is 0-100 DEG C that the condition for changing reaction, which includes: temperature,;Time is 0.1-24 hours, preferably 2-3 hours.
Fourth aspect, the present invention provides a kind of method for preparing present invention precursor compound above-mentioned, this method includes
Following steps:
(1) nitrone shown in Formula II is reacted with Grignard Reagent, obtains azanol shown in formula III;
(2) azanol shown in the formula III is subjected to reduction reaction, obtains amine shown in formula IV;
(3) under alkaline condition, amine shown in the formula IV is subjected to protection reaction, obtains Formula V compound represented;
(4) the Formula V compound represented is subjected to oxidation reaction, obtains ketone shown in Formula IV;
(5) ketone shown in the Formula IV is subjected to reduction reaction, obtains alcohol shown in Formula VII;
(6) alcohol shown in the Formula VII is subjected to sulfonating reaction, obtains Formula VIII compound represented;
(7) Formula VIII compound represented is subjected to deprotection reaction, obtains amine shown in Formula IX;
(8) amine shown in Formula IX is subjected to ring closure reaction, obtains precursor compound shown in Formula XIV;
Wherein, R3、R8And R7Definition it is identical as present invention definition above-mentioned;
R in Formula V-Formula VIII4Correspondence is identical, and R4Selected from tertbutyloxycarbonyl, fluorenylmethoxycarbonyl, acetyl group, allyl, benzyl
At least one of benzyloxycarbonyl group obtained by hydrogen atom in oxygen carbonyl and phenyl ring is replaced by methoxyl group or halogen
R in Formula VIII and Formula IX5It is identical, and R5Selected from mesyl, trifyl, benzenesulfonyl, to toluene sulphur
At least one of benzenesulfonyl obtained by hydrogen atom on acyl group and phenyl ring is replaced by methoxyl group or halogen,
The spatial configuration of 1,2 and 3 carbon in Formula II-Formula IX respectively in the compound of structure shown in Formula XIV 1,2 and
The spatial configuration of 3 carbon corresponds to identical;The spatial configuration of 4 carbon in formula III-Formula IX is identical, is R or S configuration;Formula VII-formula
The spatial configuration of 8 carbon in IX is identical, is R or S configuration.
Preferably, in step (1), the Grignard Reagent is prepared by the bromo- 1- amylene of 5-.Nitre shown in the Formula II
The dosage molar ratio of ketone and Grignard Reagent is 1:(1-100), preferably 1:(1.5-10).Nitrone and Grignard Reagent shown in Formula II into
The condition of row reaction includes: that temperature is subzero 80 DEG C to 100 DEG C above freezing, preferably subzero 10 DEG C to 20 DEG C above freezing;Time is
0.1-100h, preferably 3-60h.
Preferably, in step (2), the reduction reaction carries out in the presence of a reducing agent.The reducing agent includes but not
It is limited at least one of zinc powder-copper acetate and its hydrate and zinc powder-acid.When the reducing agent be zinc powder-copper acetate and its
When hydrate, the dosage molar ratio of azanol, zinc powder shown in formula III and copper acetate is 1:(10-100): (0.1-1), preferably
1:(10-20): (0.1-0.5), and the solvent of the reduction reaction is preferably glacial acetic acid, the condition of the reduction reaction includes:
Temperature be 0-100 DEG C, preferably 10-55 DEG C, time 0.1-100h, preferably 4-24h.When the reducing agent is zinc powder-acid
When, the dosage molar ratio of azanol, zinc powder shown in formula III is 1:(10-100), preferably 1:(10-20), in the reducing agent
Acid be preferably ammonium chloride saturated solution, the solvent of the reduction reaction is methanol, and the condition of the reduction reaction includes: temperature
Degree be 0-100 DEG C, preferably 10-55 DEG C, time 0.1-100h, preferably 4-24h.
Preferably, in step (3), the alkaline condition is formed by the presence of alkaline matter.The alkaline matter
It include organic base and/or inorganic base.The protection reaction carries out in the presence of protectant, amine shown in the formula IV, alkali
Property substance and protectant dosage molar ratio be 1:(1-100): (1-100), preferably 1:(1-10): (1-20);The protection
The condition of reaction include: temperature be 0-100 DEG C, preferably 10-55 DEG C, time 0.1-100h, preferably 0.5-8h.
Preferably, in step (4), the oxidation reaction carries out in the presence of palladium salt and mantoquita.The palladium salt is chlorine
Change palladium and/or palladium acetate;The mantoquita include but are not limited to stannous chloride, cuprous bromide, copper chloride, copper bromide, copper sulphate,
Copper acetate and its hydrate.The dosage molar ratio of the Formula V compound represented, palladium salt and mantoquita is 1:(0.1-10): (0.1-
10);Preferably 1:(0.1-0.5): (0.1-1).The condition of the oxidation reaction includes: that temperature is 0-100 DEG C, preferably 5-55
DEG C, time 0.1-200h, preferably 24-100h.
Preferably, in step (5), the reduction reaction carries out in the presence of a reducing agent, and the reducing agent is selected from hydrogenation
Aluminium lithium, diisobutyl aluminium hydride, sodium borohydride, sodium cyanoborohydride, borine (such as borine-tetrahydrofuran and/or borine-two
Methyl sulfide), in bis- (2- methoxyethoxy) sodium aluminates (red aluminum) of dihydro and 3-sec-butyl lithium borohydride (L-Selectride)
It is at least one.The dosage molar ratio of ketone shown in the Formula IV and reducing agent is 1:(1-100), preferably 1:(1-10).It is described
The condition of reduction reaction includes: that temperature is subzero 80 DEG C to 100 DEG C above freezing, and preferably subzero 10 DEG C to 25 DEG C above freezing, the time is
0.1-100h, preferably 0.5-1h.
Preferably, in step (6), the sulfonating reaction carries out in the presence of alkaline matter and sulfonylation agent.It is described
Alkaline matter includes organic base and/or inorganic base.The dosage of alcohol shown in the Formula VII, sulfonylation agent and alkaline matter
Molar ratio is 1:(1-10): (1-100);Preferably 1:(1-5): (1.5-20).The condition of the sulfonating reaction includes: that temperature is
Subzero 80 DEG C to 100 DEG C above freezing, preferably subzero 10 DEG C to 25 DEG C above freezing;Time is 0.1-100h, preferably 0.5-8h.
Preferably, in step (7), when protecting group is tertbutyloxycarbonyl, deprotection reaction carries out in acid condition,
The acid condition is formed in the presence of acidic materials, and the acidic materials include hydrochloric acid, sulfuric acid, trifluoroacetic acid, boron trifluoride
And boron chloride;The Formula VIII compound represented and the dosage molar ratio of acidic materials are 1:(1-1000), preferably 1:
(1-100);The condition of the deprotection reaction includes: that temperature is subzero 80 DEG C to 100 DEG C above freezing, 10 DEG C to zero preferably subzero
Upper 25 DEG C;Time is 0.1-100h, preferably 0.5-8h.When protecting group is benzyloxycarbonyl group, deprotection reaction is in catalytic hydrogenation
Under the conditions of carry out, the catalyst in the catalytic hydrogenation conditions includes but is not limited to palladium carbon, palladium black, palladium dydroxide, palladium chloride, oxygen
Change platinum and platinum black;Hydrogen source in the catalytic hydrogenation conditions includes but is not limited to hydrogen, ammonium formate, connection imido, cyclohexene and ring
Hexadiene;The Formula VIII compound represented and the dosage weight ratio of catalyst are 1:(0.1-10), preferably 1:(0.1-
0.5);The condition of the deprotection reaction includes: that temperature is subzero 80 DEG C to 100 DEG C above freezing, and preferably subzero 10 DEG C extremely above freezing
25℃;Time is 0.1-100h, preferably 2-24h.
Preferably, in step (8), the ring closure reaction carries out in the presence of a basic.The alkaline matter wraps
Include organic base and/or inorganic base.The dosage weight ratio of amine shown in the Formula IX and the alkaline matter is 1:(0.1-10);It is excellent
It is selected as 1:(0.1-0.5).The condition of the ring closure reaction includes: that temperature is subzero 80 DEG C to 100 DEG C above freezing, preferably 10-45
℃;Time is 0.1-100h, preferably 10-40h.
Preferably, the organic base includes triethylamine, diisopropyl ethyl amine, tetramethylethylenediamine, pyridine, hexahydro pyrrole
Pyridine, 2,4,6- trimethylpyridine and tetrabutyl ammonium fluoride;The inorganic base includes sodium hydroxide, potassium hydroxide, lithium hydroxide, carbon
Sour sodium, potassium carbonate, sodium bicarbonate, cesium carbonate and tetrabutylammonium hydroxide.
5th aspect, the present invention provides a kind of method for preparing present invention precursor compound above-mentioned, this method includes
Following steps:
(1) nitrone shown in Formula II is reacted with Grignard Reagent, obtains azanol shown in formula III;
(2) azanol shown in the formula III is subjected to reduction reaction, obtains amine shown in formula IV;
(3) under alkaline condition, amine shown in the formula IV is subjected to protection reaction, obtains Formula V compound represented;
(4) Formula V compound represented is subjected to oxidation reaction, obtains aldehyde shown in Formula X;
(5) aldehyde shown in Formula X is reacted with Grignard Reagent, obtains alcohol shown in Formula XI;
(6) alcohol shown in Formula XI is subjected to sulfonating reaction, obtains Formula XII compound represented;
(7) Formula XII compound represented is subjected to deprotection reaction, obtains amine shown in Formula XIII;
(8) amine shown in Formula XIII is subjected to ring closure reaction, obtains precursor compound shown in Formula XIV;
Wherein, R3、R8And R7Definition it is identical as present invention definition above-mentioned;
R in Formula V and Formula X-Formula XII4Correspondence is identical, and R4Definition it is identical as present invention definition above-mentioned;
R in Formula XII-Formula XIII5It is identical, and R5Definition it is identical as present invention definition above-mentioned;
R in Formula XI and Formula XIII6It is identical, and R6Linear chain or branched chain saturated alkyl, allyl, propylidene selected from C1-C12
At least one of the benzyl that hydrogen atom on base, acetyl group, benzoyl, benzyl and phenyl ring is replaced by methoxyl group or halogen;
The spatial configuration change with structure shown in Formula XIV respectively of 1,2 and 3 carbon in Formula II-Formula V and Formula X-Formula XIII
The spatial configuration of 1,2 and 3 carbon in conjunction object corresponds to identical;The three-dimensional structure of 4 carbon in formula III-Formula V and Formula X-Formula XIII
Type is identical, is R or S configuration;The spatial configuration of 8 carbon in Formula XI-Formula XIII is identical, is R or S configuration.
The step of involved in the preparation method of the fifth aspect of the present invention (1), (2) and (3) and the fourth aspect of the present invention
Preparation method in corresponding step (1), (2) and (3) it is identical, therefore, it is for the present invention 5th aspect preparation method in
The operating method and parameter of the step of being related to (1), (2) and (3) etc. are identical as the fourth aspect of the present invention, and the present invention is herein not
It repeats again.
Preferably, in step (4), the oxidation reaction carries out in the presence of an oxidizer, and the oxidant includes four oxygen
Change at least one of osmium, potassium permanganate, potassium bichromate, chromium trioxide, ozone, sodium metaperiodate and lead tetra-acetate.The Formula V institute
The dosage molar ratio of the compound and the oxidant that show is 1:(1-100), preferably 1:(1-5).The item of the oxidation reaction
Part include: temperature be 0-100 DEG C, preferably 5-40 DEG C, time 0.1-100h, preferably 2-24h.
Preferably, in step (5), the Grignard Reagent is linear chain or branched chain saturated alkyl, the allyl of halogenated C1-C12
In Grignard Reagent prepared by benzyl obtained by hydrogen atom on base, benzyl and phenyl ring is replaced by methoxyl group or halogen at least
It is a kind of;The dosage molar ratio of aldehyde shown in the Formula X and the Grignard Reagent is 1:(1-100), preferably 1:(1-5).Formula X institute
The condition that the aldehyde shown is reacted with Grignard Reagent includes: that temperature is subzero 80 DEG C to 100 DEG C above freezing, and preferably subzero 10 DEG C extremely
25 DEG C above freezing;Time is 0.1-100h, preferably 2-24h.
Preferably, in step (6), the sulfonating reaction carries out in the presence of alkaline matter and sulfonylation agent, institute
Stating alkaline matter includes organic base and/or inorganic base.The dosage of alcohol shown in the Formula XI, sulfonylation agent and alkaline matter
Molar ratio is 1:(1-10): (1-100), preferably 1:(1-5): (1.5-20).The condition of the sulfonating reaction includes: that temperature is
Subzero 80 DEG C to 100 DEG C above freezing, preferably subzero 10 DEG C to 25 DEG C above freezing;Time is 0.1-100h, preferably 0.5-8h.
Preferably, in step (7), when protecting group is tertbutyloxycarbonyl, deprotection reaction carries out in acid condition,
The acid condition is formed in the presence of acidic materials, and the acidic materials include hydrochloric acid, sulfuric acid, trifluoroacetic acid, boron trifluoride
And boron chloride;The Formula XII compound represented and the dosage molar ratio of acidic materials are 1:(1-1000), preferably 1:
(1-100);The condition of the deprotection reaction includes: that temperature is subzero 80 DEG C to 100 DEG C above freezing, 10 DEG C to zero preferably subzero
Upper 25 DEG C;Time is 0.1-100h, preferably 0.5-8h.When protecting group is benzyloxycarbonyl group, deprotection reaction is in catalytic hydrogenation
Under the conditions of carry out, the catalyst in the catalytic hydrogenation conditions includes but is not limited to palladium carbon, palladium black, palladium dydroxide, palladium chloride, oxygen
Change platinum and platinum black;Hydrogen source in the catalytic hydrogenation conditions includes but is not limited to hydrogen, ammonium formate, connection imido, cyclohexene and ring
Hexadiene;The Formula XII compound represented and the dosage weight ratio of catalyst are 1:(0.1-10), preferably 1:(0.1-
0.5);The condition of the deprotection reaction includes: that temperature is subzero 80 DEG C to 100 DEG C above freezing, preferably 0-45 DEG C;Time is
0.1-100h, preferably 2-24h.
Preferably, in step (8), the ring closure reaction carries out in the presence of a basic.The alkaline matter wraps
Include organic base and/or inorganic base.The dosage weight ratio of amine shown in the Formula XIII and the alkaline matter is 1:(0.1-10),
Preferably 1:(0.1-0.5).The condition of the ring closure reaction includes: that temperature is subzero 80 DEG C to 100 DEG C above freezing, preferably 0-45
℃;Time is 0.1-100h, preferably 10-50h.
Preferably, the organic base includes triethylamine, diisopropyl ethyl amine, tetramethylethylenediamine, pyridine, hexahydro pyrrole
Pyridine, 2,4,6- trimethylpyridine and tetrabutyl ammonium fluoride;The inorganic base includes sodium hydroxide, potassium hydroxide, lithium hydroxide, carbon
Sour sodium, potassium carbonate, sodium bicarbonate, cesium carbonate and tetrabutylammonium hydroxide.
6th aspect, the present invention provides the precursor compound of iminosugar above-mentioned or iminosugar above-mentioned or its
Application of the pharmaceutically acceptable salt in the drug that preparation inhibits glycosidase activity.
Preferably, the glycosidase is selected from alpha-glucosidase, beta-glucosidase, alpha-galactosidase, beta galactose
Glycosides enzyme, alpha-Mannosidase, beta-Mannosidase, alpha-L-fucosidase, trehalase, amyloglucosidase and α-L- mouse
At least one of Lee's glycosidase.
7th aspect, the present invention provides iminosugars above-mentioned or its pharmaceutically acceptable salt to prevent in preparation
And/or treat answering in diabetes, prevention and/or treatment gaucher's disease, prevention and/or treatment tumour and antiviral drug
With.
In the drug, one or more pharmaceutically acceptable carriers can also be added.The carrier includes pharmacy
Diluent, excipient, filler, adhesive, wetting agent, disintegrating agent, sorbefacient, the surfactant, suction of field routine
Appendix body, lubricant and other additives.
The drug can be a variety of shapes such as injection, tablet, pulvis, granule, capsule, oral solution, paste, creme
Formula.The drug of above-mentioned various dosage forms can be prepared according to the conventional method of pharmaceutical field.
The drug can be administered using various administration routes, including but not limited to oral, sucking, rectum, transdermal, transmucosal
Enteral administration and subcutaneous, muscle or intravenous injection administration.
Drug of the present invention can be administered alone, or with known other treatment diabetes, antiviral, antibacterial and anti-swollen
Tumor medicine is administered together.
The advantages of method of the invention further includes in detail below:
Using polyhydroxy nitrone as starting material, the Indolizidine with certain bioactivity is prepared for by multistep reaction
Class iminosugar realizes succinct, the efficient preparation of such compound.The raw materials used in the present invention can by cheap xylose,
The preparation such as arabinose, ribose and malic acid, raw material are easy to get, and preparation method is simple, mild condition, and the purifying of intermediate is held
Easily.Method of the invention is easily achieved a large amount of synthesis, can synthesize a large amount of Indolizidine class iminosugars in a short time, for sieve
Choosing has the compound of bioactivity and medical value to provide solid foundation.
The present invention will be described in detail by way of examples below.
In the case where no explanation on the contrary, various raw materials used below are all from commercially available.
Preparation example: preparation formula II-1 to II-6 compound represented is (using side identical with compound shown in preparation II-1
Method and corresponding raw material sugar prepare II-2 to II-4 and II-6 compound represented)
Ice bath under stirring condition, is added dropwise 10mL chloroacetic chloride into the dry methanol of 500mL, D- xylose is then added
(0.2mol), keeps zero degree reaction until raw material disappearance, is neutralized to neutrality with sodium bicarbonate, filtering removal inorganic salts are evaporated molten
Crude product D- furyl xylose first glycosides obtained by agent directly throws the next step.
Upper step crude product D- furyl xylose first glycosides (calculating according to 0.2mol) is dissolved into dry DMF (200mL), and
It is added drop-wise in the THF containing NaH (0.72mol) (200mL) and DMF (200mL), finishes dropwise, TBAI (tetrabutyl iodate is added
Ammonium) (2.0g), it after half an hour, is added dropwise BnBr (0.66mol), reaction disappears until raw material, and saturated ammonium chloride is slowly added dropwise
Aqueous solution quenching reaction, ethyl acetate/water extraction, washing organic phase remove DMF, and solvent evaporated obtains 2,3,5-O- tri- benzyl of crude product
Base-D- furyl xylose first glycosides, directly throwing the next step.
Upper step crude product 2,3,5-O- tribenzyl-D- furyl xylose first glycosides (calculating by 0.2mol) is dissolved into 80 weight %
Acetic acid aqueous solution in (150mL) and Isosorbide-5-Nitrae-dioxane (150mL) in the mixed solvent, add aqueous sulfuric acid (1mol/
L, 150mL), reflux almost disappears until raw material, solvent evaporated, with ethyl acetate/saturated sodium carbonate solution extraction, is evaporated
Organic phase obtains crude product (hemiacetal crude product) (2,3,5-O- tribenzyl-D- furyl xylose) and directly throws into reaction in next step.
Above-mentioned crude product 2,3,5-O- tribenzyl-D- furyl xylose is added in pyridine (0.37mol) (to count according to 0.2mol
Calculate) methylene chloride (100mL) solution in, be charged with O- methyl hydroxylamine hydrochloride (0.25mol), after 12h is stirred at room temperature,
Solvent is evaporated, ethyl acetate (150mL) and hydrochloric acid (1mol/L, 30mL) are then added into concentrate, by extracting and demixing,
Merge organic phase, dry, concentration obtains crude product (2S, 3S, 4R) -2,3,5- tri- benzyloxy -4- hydroxyl -1- valeral methyloxime ethers,
It directly throws into reaction in next step.
Three benzyloxy -4- hydroxyl -1- valeral methyloxime ether of above-mentioned crude product (2S, 3S, 4R) -2,3,5- (is pressed into 0.2mol
Calculate) it is dissolved in methylene chloride (100mL), pyridine (0.37mol) and methane sulfonyl chloride (0.20mol) is added, after 8h is stirred at room temperature,
Aqueous hydrochloric acid solution (1mol/L) is added, the reaction is quenched.By extracting and demixing, merge organic phase, dry, concentration obtains crude product
(2S, 3S, 4R) -2,3,5- tri- benzyloxy -4- sulfonyloxy methyl oxygen -1- valeral methyloxime ethers are directly used in and react in next step.
It (is pressed toward three benzyloxy -4- sulfonyloxy methyl oxygen -1- valeral methyloxime ether of above-mentioned crude product (2S, 3S, 4R) -2,3,5-
0.2mol calculate) tetrahydrofuran (300mL) solution in be added p-methyl benzenesulfonic acid (0.2mol) and 37 weight % formaldehyde it is water-soluble
Liquid (50mL) is stirred at room temperature until raw material completely disappears, and then addition ethyl acetate and water into mixed liquor, divide by extraction
Layer merges organic phase, dry, concentration, gained crude product (2R, 3R, 4R) -4- mesyloxy -2,3, tri- benzyloxy -1- penta of 5-
Aldehyde.
First sodium bicarbonate (0.45mol) is added in the aqueous solution (50mL) of hydroxylamine hydrochloride (0.45mol), is added thereto
The ethyl alcohol of above-mentioned three benzyloxy -1- valeral of crude product (2R, 3R, 4R) -4- mesyloxy -2,3,5- (calculating by 0.2mol) is molten
15h, rear heating stirring 48h is stirred at room temperature in liquid (200mL).Then ethyl acetate and water are added into mixed liquor, by extraction point
Layer merges organic phase, dry, and concentration obtains yellow oil.The grease is dissolved in ethyl acetate and petroleum ether, room temperature is put
It sets overnight, white solid 10.40g is precipitated, mother liquor continues to crystallize, 9.95g white solid of getting back, and mother liquor is purified by column chromatography
After get back white solid 1.35g, amount to 22.00g nitrone product ((3S, 4S, 5S) -3,4- benzyloxy -5- benzyloxymethyl -
1- pyrrolin-N- oxide), as -1 compound represented of Formula II.It is calculated by raw material of xylose, seven steps reaction gross production rate is
26%.
Its structural identification data is: m.p.:90-91 DEG C;[α] D=+45 ° of (c 0.4, CHCl3);IR(cm-1): 3049
(w), 2945,2923,2901,2884,2868,2851 (w), 1593 (s), 1551 (s), 1496 (s), 1452 (s), 1361 (s),
1247 (vs), 1131 (vs), 1247 (vs), 1028 (vs);1H-NMR (300MHz, CDCl3): δ 7.38-7.26 (m, 15H),
6.91 (d, J=1.9Hz, 1H), 4.69-4.67 (m, 1H), 4.64-4.46 (m, 6H), 4.39 (dd, J=3.2,2.2Hz, 1H),
4.10-4.04 (m, 2H), 3.78 (d, J=7.3Hz, 1H);13C-NMR (75MHz, CDCl3): δ 66.03,71.67,71.91,
73.47,80.30,82.74,127.70,127.75,127.92,128.14,128.17,128.38,128.55,128.61,
133.02,137.06,137.16,137.63;FT-ICRMS:m/z 418.2007 [M+H]+(C26H28NO4requires
418.2013)。
Preparation formula II-5 compound represented:
Under ice-water bath, thionyl chloride is added dropwise into the dehydrated alcohol (600mL) of L-TARTARIC ACID (0.67mol)
(1.47mol), room temperature reaction is overnight.Morning next day end of reaction, low-temperature reduced-pressure are spin-dried for solvent, ethyl acetate dissolution, unsaturated carbonate
Hydrogen sodium water solution is washed till neutrality, and drying is concentrated to give colorless oil as product ethyl tartrate, yield 94%.
Ethyl tartrate (36.4mmol) is dissolved into dry N,N-dimethylformamide (100mL) and tetrahydrofuran
In (50mL), gains are added dropwise to the tetrahydrofuran of NaH (2.4 times of equivalents, 80mmol, 60%) under the conditions of -20 DEG C
In (50mL), be added the tetrabutylammonium iodide of catalytic amount, keep 10min, be slowly added dropwise BnBr (2.2 times of equivalents,
73.35mmol), -20 DEG C of reactions, TLC (petrol ether/ethyl acetate 5:1) monitoring reaction are kept.End of reaction, to be saturated chlorination
The careful quenching reaction of aqueous ammonium, ethyl acetate/saturated aqueous ammonium chloride extraction, washing removal n,N-Dimethylformamide,
Dry, concentration, column chromatograph double benzyl protections ethyl tartrate, yield 82%.
The ethyl tartrate (112mmol) of double benzyl protections is dissolved into the dry ether of 500mL, under ice-water bath,
It is added portionwise Lithium Aluminium Hydride (2 times of equivalents, 224mmol), after reacting at room temperature 30min, ice is carefully quenched to 0 DEG C with ethyl acetate
Reaction is slowly added dropwise saturated aqueous ammonium chloride to system and clarifies, pours out supernatant, and ethyl acetate/water extracts paste, merges
Organic phase, dry, concentration, column chromatography (petrol ether/ethyl acetate 3:2) obtain oil product glycol, yield 93%.
The glycol (0.66mmol) that upper step is reacted is dissolved into the dry methylene chloride of 5mL, and triethylamine (2.5 is added
Times equivalent, 1.65mmol), under ice-water bath, it is added dropwise methylsufonyl chloride (2.2 times of equivalents, 1.45mmol), room temperature reaction 1 is small
When fully reacting, decompression is spin-dried for solvent, and ethyl acetate/saturated aqueous ammonium chloride extraction merges organic phase, dry, concentration, column
It chromatographs (petrol ether/ethyl acetate 3:1) and obtains the double methylsulfonyl esters of rufous oil product, yield 91%.
Double methylsulfonyl esters (0.60mmol) are dissolved into the dry triethylamine of 10mL, addition hydroxylamine hydrochloride (4 times of equivalents,
2.4mmol), back flow reaction 1.5 hours, fully reacting, decompression are spin-dried for solvent, and ethyl acetate/saturated aqueous ammonium chloride extracts,
Merge organic phase, dry, concentration, column chromatography (petrol ether/ethyl acetate 2:1) obtain oil product cyclic hydroxylamine, yield 84%.
Cyclic hydroxylamine (0.50mmol) is dissolved into the dry methylene chloride of 5mL, under ice bath, yellow mercury oxide (2 is added
Times equivalent, 1.0mmol), room temperature reaction overnight, fully reacting (TLC petrol ether/ethyl acetate 1:2), diatomite filtering, decompression
It is spin-dried for solvent, concentration, column chromatography (petrol ether/ethyl acetate 1:2) obtain oil product II-5, yield 94%.
Its structural identification data is:1H NMR (300MHz, CDCl3) δ 7.43-7.28 (m, 10H), 6.89 (d, J=
1.7Hz,1H),4.69(s,1H),4.58(s,2H),4.56(s,2H),4.32–4.25(m,2H),3.91-3.83(m,1H).13C
NMR(75MHz,CDCl3)δ136.8,136.7,132.2,128.6,128.5,128.3,128.2,128.0,127.9,83.7,
78.4,72.0,71.9,66.9.
Embodiment 1: prepare Indolizidine class iminosugar I-1a, I-1b and its intermediate
It is bromo- that 5- is added under argon gas protection, in the tetrahydrofuran of steaming again (15mL) suspension for the magnesium chips (24mmol) newly polished
1- amylene (17mmol) is heated to 50 DEG C of reactions, and a large amount of bubbles occurs in system, and solution is in Dark grey, the reaction was continued 0.5h.By nitre
Ketone II-1 (12mmol) is dissolved in dry tetrahydrofuran, and under condition of ice bath, above-mentioned Grignard Reagent is added dropwise by syringe
Enter, adds within 15 minutes, the reaction was continued 1h, TLC monitoring display raw material disappearance, addition saturated ammonium chloride solution quenching reaction, acetic acid
Ethyl ester extraction directly removes solvent under vacuum and obtains the crude product of III-1 without drying.
The crude product of III-1 is dissolved in acetic acid, preactivated good zinc powder (0.12mol) and Cu (OAc) are added to2(contain
Two molecular crystalline water, 1.2mmol) glacial acetic acid mixture in (the processed zinc powder of dilute hydrochloric acid and copper acetate are placed in glacial acetic acid
Middle stirring, until rufous occurs in system), system is highly exothermic, and overnight, TLC monitoring display raw material reacts completely for room temperature reaction,
Solvent is removed under vacuum, obtained solid is washed through ethyl acetate, and NaOH saturated solution adjusts pH=9 or so, ethyl acetate extraction
Water phase merges organic phase, and anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of IV-1.
By the crude product of IV-1 in methylene chloride (20mL), it is added triethylamine (15mmol) and (Boc)2O (13mmol), room
Temperature reaction 2h, TLC monitoring raw material point completely disappears, and saturated ammonium chloride quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is added
It is dry, it filters and removes solid, solvent is removed under vacuum, column chromatography (petroleum ether: ethyl acetate=30:1) obtains alkene V-1, is
Colorless viscous shape liquid 3.2g, yield 48%.Structural identification:
1H NMR(300MHz,CDCl3) δ 7.34 (dt, J=19.1,7.7Hz, 15H), 5.87 (dq, J=11.1,7.0Hz,
1H), 5.05 (t, J=14.8Hz, 2H), 4.79-4.41 (m, 6H), 4.33 (dd, J=10.4,3.8Hz, 0.5H), 4.27 (d, J
=7.9Hz, 1H), 4.21-4.08 (m, 1H), 4.01-3.83 (m, 2H), 3.78 (d, J=9.1Hz, 0.5H), 3.58 (dd, J=
19.0,9.3Hz,1H),2.28–1.99(m,3H),1.97–1.64(m,2H),1.60–1.24(m,12H).13C NMR(75MHz,
CDCl3)δ154.16,153.79,138.76,138.56,138.45,138.13,137.87,137.82,129.76,128.53,
128.46,128.44,128.38,127.76,127.74,127.64,127.54,114.87,114.60,84.72,83.43,
83.38,81.92,79.66,79.60,77.73,77.31,76.88,73.09,73.06,71.30,71.05,70.93,
68.86,68.10,64.73,64.50,62.74,62.57,33.72,33.60,31.20,30.07,28.62,28.58,
26.18,26.11。
Substrate V-1 (2.4mmol) is dissolved in 10mL in the mixed solvent, palladium acetate (0.96mmol) and copper acetate (band is added
The crystallization water, 4.8mmol), it is reacted at room temperature 4 days under oxygen atmosphere, TLC monitors fully reacting, and saturated ammonium chloride is added and is quenched instead
It answers, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of ketone VI-1.
Under condition of ice bath, the crude product (in terms of 2mmol) of VI-1 is dissolved in the methanol of 15mL, sodium borohydride is slowly added to
(2.5mmol) adds rear system into light gray, and TLC monitoring raw material point disappears after 30min, and saturated ammonium chloride quenching reaction is added,
Methanol is removed under vacuum, the thick white oil object of gained is redissolved in saturated ammonium chloride, ethyl acetate extraction, anhydrous slufuric acid
Magnesium is dry, filters and removes solid, removes solvent under vacuum and obtains the crude product of VII-1.
The crude product of VII-1 is redissolved in 5mL dry methylene chloride, is added triethylamine (3mmol), is delayed under condition of ice bath
It is slow that methylsufonyl chloride (2.4mmol) is added, it adds and moves back except ice bath, react at room temperature 1h, TLC monitors raw material point and disappears, and is added full
With ammonium chloride quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain
The crude product of VIII-1.
VIII-1 is redissolved in 5mL methylene chloride, 3mL trifluoroacetic acid is added, after reacting 1h, TLC shows that raw material disappears
It loses, obtains the big product of a polarity, saturation NaHCO is added3Quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes
Solid removes solvent under vacuum and obtains the crude product of IX-1.
The crude product of IX-1 is redissolved in 10mL methanol, 100mg Anhydrous potassium carbonate is added, reacts at room temperature 48h, TLC prison
It surveys lesser two product points of polarized to generate, removes methanol under vacuum, the thick grease of gained is redissolved in saturation chlorination
In ammonium, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, and solvent is removed under vacuum, and column chromatographs (petroleum ether: second
Acetoacetic ester=15:1) obtain the polarity total 204mg of lesser point (XIV-1a), the total 225mg of the biggish point (XIV-1b) of polarity.Structure
Confirmation:
XIV-1a:1H NMR(400MHz,CDCl3)δ7.41–7.28(m,15H),4.74–4.46(m,6H),3.96(d,J
=2.6Hz, 1H), 3.77 (dd, J=8.8,3.9Hz, 1H), 3.72 (dd, J=7.7,2.6Hz, 1H), 3.62 (dd, J=9.2,
3.7Hz, 1H), 3.51 (t, J=9.0Hz, 1H), 2.65-2.59 (m, 2H), 2.00 (d, J=8.8Hz, 2H), 1.87-1.68
(m, 1H), 1.60 (d, J=9.1Hz, 1H), 1.31-1.20 (m, 4H), 1.17 (d, J=6.1Hz, 3H);13C NMR(101MHz,
CDCl3)δ138.67,138.56,138.44,128.47-127.57,90.43,85.50,73.61,71.95,71.32,
65.41,64.28,62.89,52.13,34.40,30.79,24.19,20.30。
XIV-1b:1H NMR(400MHz,CDCl3)δ7.38–7.28(m,16H),4.65–4.50(m,6H),3.96(t,J
=3.2Hz, 1H), 3.93 (dd, J=6.5,3.2Hz, 1H), 3.62 (dd, J=9.3,5.5Hz, 1H), 3.50 (t, J=
8.7Hz,1H),3.38-3.31(m,2H),3.01–2.94(m,1H),1.79–1.69(m,2H),1.66-1.54(m,3H),
1.30-1.20 (m, 3H), 1.14 (d, J=6.4Hz, 3H);13C NMR(101MHz,CDCl3)δ138.65,138.55,128.4-
127.64,88.02,85.65,73.42,72.25,71.85,71.70,66.15,59.46,51.34,29.80,24.61,
20.99,19.00。
Substrate XIV-1a (200mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, 0.5mL is added
3N hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, palladium carbon is filtered to remove by diatomite, under vacuum
Solvent is removed, is neutralized by ammonium hydroxide, is handled by acidic resins column, obtain I-1a, is weak yellow liquid 72mg, yield 85%.
Structural identification:
1H NMR(300MHz,D2O) δ 3.98 (dd, J=4.3,1.9Hz, 1H), 3.87 (dd, J=11.7,3.9Hz, 1H),
3.67 (dd, J=11.7,7.9Hz, 1H), 3.61 (dd, J=8.7,4.3Hz, 1H), 3.12-3.08 (m, 1H), 2.70-2.57
(m, 2H), 1.87 (d, J=11.8Hz, 1H), 1.73-1.62 (m, 2H), 1.28-1.11 (m, 3H), 1.05 (d, J=6.1Hz,
3H).13C NMR(75MHz,D2O)δ82.60,79.09,66.08,65.12,57.69,51.96,32.93,28.30,22.88,
18.56。
Substrate XIV-1b (200mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, 0.5mL is added
3N hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, palladium carbon is filtered to remove by diatomite, under vacuum
Solvent is removed, is neutralized by ammonium hydroxide, is handled by acidic resins column, obtain I-1b, is weak yellow liquid 76mg, yield 89%.
Structural identification:
1H NMR(400MHz,D2O) δ 4.08 (dd, J=10.5,6.2Hz, 1H), 3.81 (dd, J=5.9,5.1Hz, 1H),
3.62 (dd, J=11.6,6.6Hz, 1H), 3.52 (dd, J=11.6,6.9Hz, 1H), 2.98-2.94 (m, 2H), 2.79-2.69
(m, 1H), 1.75-1.65 (m, 2H), 1.62-1.38 (m, 3H), 1.17-1.11 (m, 1H), 1.00 (d, J=6.1Hz, 3H)
13C NMR(101MHz,D2O)δ79.87,75.57,69.34,62.28,60.22,54.94,31.76,22.37,
19.63,17.73。
Embodiment 2: prepare Indolizidine class iminosugar I-2a, I-2b and its intermediate
It is bromo- that 5- is added under argon gas protection, in the tetrahydrofuran of steaming again (15mL) suspension for the magnesium chips (24mmol) newly polished
1- amylene (17mmol) is heated to 50 DEG C of reactions, and a large amount of bubbles occurs in system, and solution is in Dark grey, and the reaction was continued half an hour.It will
Nitrone II-2 (12mmol) is dissolved in dry tetrahydrofuran, under condition of ice bath, dropwise by syringe by above-mentioned Grignard Reagent
It is added, adds within 15 minutes, the reaction was continued 1h, TLC monitoring display raw material disappearance, addition saturated ammonium chloride solution quenching reaction, second
Acetoacetic ester extraction, without drying, directly removes solvent under vacuum, obtains the crude product of azanol III-2.
The crude product of gained azanol III-2 is dissolved in acetic acid, is added to preactivated good zinc powder (0.12mol) and Cu
(OAc)2(the processed zinc powder of dilute hydrochloric acid is set with copper acetate in the glacial acetic acid mixture of (containing two molecular crystalline water, 1.2mmol)
Stirred in glacial acetic acid, until rufous occurs in system), system is highly exothermic, and overnight, TLC monitoring shows raw material for room temperature reaction
It reacts completely, removes solvent under vacuum, obtained solid is washed through ethyl acetate, and NaOH saturated solution adjusts pH=9 or so, acetic acid
Ethyl ester aqueous phase extracted merges organic phase, and anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain IV-2's
Crude product.
The crude product of gained IV-2 is dissolved in methylene chloride (20mL), is added triethylamine (15mmol) and (Boc)2O
(13mmol) reacts at room temperature 2h, and TLC monitoring raw material point completely disappears, and saturated ammonium chloride quenching reaction, ethyl acetate extraction is added
It takes, anhydrous magnesium sulfate is dry, filters and removes solid, and solvent is removed under vacuum, and column chromatographs (petroleum ether: ethyl acetate=30:1) and obtains
The colorless viscous shape liquid total 3.2g of V-2, yield 48%.Structural identification:
1H NMR(300MHz,CDCl3) δ 7.56-7.14 (m, 16H), 6.00-5.77 (m, 1H), 5.08 (t, J=
14.8Hz, 2H), 4.83-4.68 (m, 2H), 4.53 (ddd, J=18.1,15.1,8.1Hz, 5H), 4.36 (dd, J=10.4,
3.4Hz, 0.5H), 4.30 (d, J=8.2Hz, 1H), 4.25-4.11 (m, 1H), 4.03-3.87 (m, 2H), 3.82 (d, J=
10.3Hz, 0.5H), 3.61 (dd, J=19.0,9.5Hz, 1H), 2.17 (tt, J=14.6,7.2Hz, 3H), 2.02-1.66 (m,
2H),1.66–1.29(m,12H);13C NMR(75MHz,CDCl3)δ154.17,153.80,138.77,138.57,138.45,
138.13,137.87,137.82,128.54,128.47,128.45,128.39,127.78,127.75,127.65,127.55,
114.88,114.61,84.72,83.43,83.38,81.92,79.66,79.61,77.75,77.33,76.90,73.10,
73.06,71.30,71.06,70.93,68.87,68.10,64.73,64.52,62.75,62.58,33.72,33.61,
31.20,30.08,28.63,28.59,26.18,26.11。
Substrate V-2 (2.4mmol) is dissolved in 10mL in the mixed solvent, palladium acetate (0.96mmol) and copper acetate (band is added
The crystallization water, 4.8mmol), it is reacted at room temperature 4 days under oxygen atmosphere, TLC monitors fully reacting, and saturated ammonium chloride is added and is quenched instead
It answers, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of VI-2.
Under condition of ice bath, the crude product (in terms of 2mmol) of ketone VI-2 is dissolved in the methanol of 15mL, sodium borohydride is slowly added to
(2.5mmol) adds rear system into light gray, and TLC monitoring raw material point disappears after 30min, and saturated ammonium chloride quenching reaction is added,
Methanol is removed under vacuum, the thick white oil object of gained is redissolved in saturated ammonium chloride, ethyl acetate extraction, anhydrous slufuric acid
Magnesium is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of VII-2.
The crude product of gained VII-2 is redissolved in 5mL dry methylene chloride, is added triethylamine (3mmol), under condition of ice bath
It is slowly added to methylsufonyl chloride (2.4mmol), adds and moves back except ice bath, reacts at room temperature 1h, TLC monitors raw material point and disappears, is added
Saturated ammonium chloride quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain
To the crude product of VII-2.
The crude product of gained VII-2 is redissolved in 5mL methylene chloride, and 3mL trifluoroacetic acid is added, and after reacting 1h, TLC is shown
Raw material disappears, and saturation NaHCO is added3Quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, vacuum
Lower removing solvent, obtains the crude product of IX-2.
The crude product of gained IX-2 is redissolved in 10mL methanol, and 100mg Anhydrous potassium carbonate is added, and reacts at room temperature 48h, vacuum
Lower removing methanol, the thick grease of gained are redissolved in saturated ammonium chloride, and ethyl acetate extraction, anhydrous magnesium sulfate is dry,
It filters and removes solid, solvent is removed under vacuum, column chromatographs (petroleum ether: ethyl acetate=15:1), it is lesser to respectively obtain polarity
Point (XIV-2a) and the biggish point of polarity.
XIV-2a:1H NMR(400MHz,CDCl3)δ7.41–7.28(m,15H),4.74–4.46(m,6H),3.96(d,J
=2.6Hz, 1H), 3.77 (dd, J=8.8,3.9Hz, 1H), 3.72 (dd, J=7.7,2.6Hz, 1H), 3.62 (dd, J=9.2,
3.7Hz, 1H), 3.51 (t, J=9.0Hz, 1H), 2.65-2.59 (m, 2H), 2.00 (d, J=8.8Hz, 2H), 1.87-1.68
(m, 1H), 1.60 (d, J=9.1Hz, 1H), 1.31-1.20 (m, 4H), 1.17 (d, J=6.1Hz, 3H);13C NMR(101MHz,
CDCl3)δ138.67,138.56,138.44,128.47-127.57,90.43,85.50,73.61,71.95,71.32,
65.41,64.28,62.89,52.13,34.40,30.79,24.19,20.30。
XIV-2b:1H NMR(400MHz,CDCl3)δ7.38–7.28(m,16H),4.65–4.50(m,6H),3.96(t,J
=3.2Hz, 1H), 3.93 (dd, J=6.5,3.2Hz, 1H), 3.62 (dd, J=9.3,5.5Hz, 1H), 3.50 (t, J=
8.7Hz,1H),3.38-3.31(m,2H),3.01–2.94(m,1H),1.79–1.69(m,2H),1.66-1.54(m,3H),
1.30-1.20 (m, 3H), 1.14 (d, J=6.4Hz, 3H);13C NMR(101MHz,CDCl3)δ138.65,138.55,128.4-
127.64,88.02,85.65,73.42,72.25,71.85,71.70,66.15,59.46,51.34,29.80,24.61,
20.99,19.00。
Substrate XIV-2a (200mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, 0.5mL is added
3N hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, palladium carbon is filtered to remove by diatomite, under vacuum
Solvent is removed, neutralizes by ammonium hydroxide, is handled by acidic resins column, obtain the total 76mg of weak yellow liquid I-2a, yield 91%.Knot
Structure confirmation:
1H NMR(300MHz,D2O) δ 3.98 (dd, J=4.3,1.9Hz, 1H), 3.87 (dd, J=11.7,3.9Hz, 1H),
3.67 (dd, J=11.7,7.9Hz, 1H), 3.61 (dd, J=8.7,4.3Hz, 1H), 3.12-3.08 (m, 1H), 2.70-2.57
(m, 2H), 1.87 (d, J=11.8Hz, 1H), 1.73-1.62 (m, 2H), 1.28-1.11 (m, 3H), 1.05 (d, J=6.1Hz,
3H)。13C NMR(75MHz,D2O)δ82.60,79.09,66.08,65.12,57.69,51.96,32.93,28.30,22.88,
18.56。
Substrate (200mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, the 3N salt of 0.5mL is added
Acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, is filtered to remove palladium carbon by diatomite, removes under vacuum molten
Agent is neutralized by ammonium hydroxide, is handled by acidic resins column, and the total 74mg of weak yellow liquid I-2b, yield 86% are obtained.Structure is true
Card:
1H NMR(400MHz,D2O) δ 4.08 (dd, J=10.5,6.2Hz, 1H), 3.81 (dd, J=5.9,5.1Hz, 1H),
3.62 (dd, J=11.6,6.6Hz, 1H), 3.52 (dd, J=11.6,6.9Hz, 1H), 2.98-2.94 (m, 2H), 2.79-2.69
(m, 1H), 1.75-1.65 (m, 2H), 1.62-1.38 (m, 3H), 1.17-1.11 (m, 1H), 1.00 (d, J=6.1Hz, 3H).13C
NMR(101MHz,D2O)δ79.87,75.57,69.34,62.28,60.22,54.94,31.76,22.37,19.63,17.73。
Embodiment 3: Indolizidine class iminosugar I-3a, I-3b and its intermediate
It is bromo- that 5- is added under argon gas protection, in the tetrahydrofuran of steaming again (15mL) suspension for the magnesium chips (24mmol) newly polished
1- amylene (17mmol) is heated to 50 DEG C of reactions, and a large amount of bubbles occurs in system, and solution is in Dark grey, and the reaction was continued half an hour.It will
Nitrone II-3 (12mmol) is dissolved in dry tetrahydrofuran, under condition of ice bath, dropwise by syringe by above-mentioned Grignard Reagent
It is added, adds within 15 minutes, the reaction was continued 1h, TLC monitoring display raw material disappearance, addition saturated ammonium chloride solution quenching reaction, second
Acetoacetic ester extraction, without drying, directly removes solvent under vacuum, obtains III-3 crude product.
Gained III-3 crude product is dissolved in acetic acid, is added to preactivated good zinc powder (0.12mol) and Cu (OAc)2(contain
Two molecular crystalline water, 1.2mmol) glacial acetic acid mixture in (the processed zinc powder of dilute hydrochloric acid and copper acetate are placed in glacial acetic acid
Middle stirring, until rufous occurs in system), system is highly exothermic, and overnight, TLC monitoring display raw material reacts completely for room temperature reaction,
Solvent is removed under vacuum, obtained solid is washed through ethyl acetate, and NaOH saturated solution adjusts pH=9 or so, ethyl acetate extraction
Water phase merges organic phase, and anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain IV-3 crude product.
Gained IV-3 crude product is dissolved in methylene chloride (20mL), is added triethylamine (15mmol) and (Boc)2O (13mmol),
2h is reacted at room temperature, TLC monitoring raw material point completely disappears, and saturated ammonium chloride quenching reaction, ethyl acetate extraction, anhydrous slufuric acid is added
Magnesium is dry, filters and removes solid, solvent is removed under vacuum, it is total that column chromatography (petroleum ether: ethyl acetate=30:1) obtains alkene V-3
3.9g, yield 58%, structural identification:
13C NMR(75MHz,CDCl3)δ155.13,138.85,138.65,138.30,138.17,128.49,128.46,
128.34,128.00,127.84,127.81,127.75,127.70,127.48,114.56,85.29,82.86,79.71,
77.71,77.29,76.86,73.36,72.96,71.72,68.39,67.14,61.81,58.52,33.76,33.07,
28.56,25.33。
Substrate V-3 (2.4mmol) is dissolved in 10mL in the mixed solvent, palladium acetate (0.96mmol) and copper acetate (band is added
The crystallization water, 4.8mmol), it is reacted at room temperature 4 days under oxygen atmosphere, TLC monitors fully reacting, and saturated ammonium chloride is added and is quenched instead
It answers, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain VI-3 crude product.
Under condition of ice bath, substrate VI-3 (in terms of 2mmol) is dissolved in the methanol of 15mL, sodium borohydride is slowly added to
(2.5mmol) adds rear system into light gray, and TLC monitoring raw material point disappears after 30min, and saturated ammonium chloride quenching reaction is added,
Methanol is removed under vacuum, the thick white oil object of gained is redissolved in saturated ammonium chloride, ethyl acetate extraction, anhydrous slufuric acid
Magnesium is dry, filters and removes solid, removes solvent under vacuum, obtain VII-3 crude product.
Gained VII-3 crude product is redissolved in 5mL dry methylene chloride, is added triethylamine (3mmol), is delayed under condition of ice bath
It is slow that methylsufonyl chloride (2.4mmol) is added, it adds and moves back except ice bath, react at room temperature 1h, TLC monitors raw material point and disappears, and enters saturation
Ammonium chloride quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain
VIII-3 crude product.
Gained VIII-3 crude product is redissolved in 5mL methylene chloride, and 3mL trifluoroacetic acid is added, and after reacting 1h, TLC is shown
Raw material disappears, and saturation NaHCO is added3Quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, vacuum
Lower removing solvent, obtains IX-3 crude product.
Gained IX-3 crude product is redissolved in 10mL methanol, addition 100mg Anhydrous potassium carbonate, room temperature reaction 48h, under vacuum
Methanol is removed, the thick grease of gained is redissolved in saturated ammonium chloride, and ethyl acetate extraction, anhydrous magnesium sulfate is dry, takes out
Solid is filtered out, solvent is removed under vacuum, column chromatography (petroleum ether: ethyl acetate=15:1) obtains the lesser point (XIV- of polarity
3a) 211mg and biggish point (XIV-3b) 209mg of polarity, yield 43%.Structural identification:
XIV-3a:1H NMR(400MHz,CDCl3)δ7.41–7.28(m,15H),4.74–4.46(m,6H),3.96(d,J
=2.6Hz, 1H), 3.77 (dd, J=8.8,3.9Hz, 1H), 3.72 (dd, J=7.7,2.6Hz, 1H), 3.62 (dd, J=9.2,
3.7Hz, 1H), 3.51 (t, J=9.0Hz, 1H), 2.65-2.59 (m, 2H), 2.00 (d, J=8.8Hz, 2H), 1.87-1.68
(m, 1H), 1.60 (d, J=9.1Hz, 1H), 1.31-1.20 (m, 4H), 1.17 (d, J=6.1Hz, 3H);13C NMR(101MHz,
CDCl3)δ138.67,138.56,138.44,128.47-127.57,90.43,85.50,73.61,71.95,71.32,
65.41,64.28,62.89,52.13,34.40,30.79,24.19,20.30。
XIV-3b:1H NMR(400MHz,CDCl3)δ7.38–7.28(m,16H),4.65–4.50(m,6H),3.96(t,J
=3.2Hz, 1H), 3.93 (dd, J=6.5,3.2Hz, 1H), 3.62 (dd, J=9.3,5.5Hz, 1H), 3.50 (t, J=
8.7Hz,1H),3.38-3.31(m,2H),3.01–2.94(m,1H),1.79–1.69(m,2H),1.66-1.54(m,3H),
1.30-1.20 (m, 3H), 1.14 (d, J=6.4Hz, 3H);13C NMR(101MHz,CDCl3)δ138.65,138.55,128.4-
127.64,88.02,85.65,73.42,72.25,71.85,71.70,66.15,59.46,51.34,29.80,24.61,
20.99,19.00。
Substrate XIV-3a (200mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, 0.5mL is added
3N hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, palladium carbon is filtered to remove by diatomite, under vacuum
Solvent is removed, is neutralized by ammonium hydroxide, is handled by acidic resins column, obtain I-3a, is weak yellow liquid 69mg, yield 82%.
Structural identification:
1H NMR(300MHz,D2O) δ 3.98 (dd, J=4.3,1.9Hz, 1H), 3.87 (dd, J=11.7,3.9Hz, 1H),
3.67 (dd, J=11.7,7.9Hz, 1H), 3.61 (dd, J=8.7,4.3Hz, 1H), 3.12-3.08 (m, 1H), 2.70-2.57
(m, 2H), 1.87 (d, J=11.8Hz, 1H), 1.73-1.62 (m, 2H), 1.28-1.11 (m, 3H), 1.05 (d, J=6.1Hz,
3H);13C NMR(75MHz,D2O)δ82.60,79.09,66.08,65.12,57.69,51.96,32.93,28.30,22.88,
18.56。
Substrate XIV-3b (200mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, 0.5mL is added
3N hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, palladium carbon is filtered to remove by diatomite, under vacuum
Solvent is removed, neutralizes by ammonium hydroxide, is handled by acidic resins column, obtain weak yellow liquid I-3b 73mg, yield 85%.Knot
Structure confirmation:
1H NMR(400MHz,D2O) δ 4.08 (dd, J=10.5,6.2Hz, 1H), 3.81 (dd, J=5.9,5.1Hz, 1H),
3.62 (dd, J=11.6,6.6Hz, 1H), 3.52 (dd, J=11.6,6.9Hz, 1H), 2.98-2.94 (m, 2H), 2.79-2.69
(m, 1H), 1.75-1.65 (m, 2H), 1.62-1.38 (m, 3H), 1.17-1.11 (m, 1H), 1.00 (d, J=6.1Hz, 3H)13C
NMR(101MHz,D2O)δ79.87,75.57,69.34,62.28,60.22,54.94,31.76,22.37,19.63,17.73。
Embodiment 4: prepare Indolizidine class iminosugar I-4a, I-4b and its intermediate
Under argon gas protection, the bromo- 1- of 5- is added in the tetrahydrofuran of steaming again (15mL) suspension for the magnesium chips (4mmol) newly polished
Amylene (17mmol) is heated to 50 DEG C of reactions, and a large amount of bubbles occurs in system, and solution is in Dark grey, and the reaction was continued half an hour.By nitre
Ketone II-4 (12mmol) is dissolved in dry tetrahydrofuran, and under condition of ice bath, above-mentioned Grignard Reagent is added dropwise by syringe
Enter, adds within 15 minutes, the reaction was continued 1h, TLC monitoring display raw material disappearance, addition saturated ammonium chloride solution quenching reaction, acetic acid
Ethyl ester extraction, without drying, directly removes solvent under vacuum, obtains the crude product of III-4.
The crude product of gained III-4 is dissolved in acetic acid, is added to preactivated good zinc powder (0.12mol) and Cu (OAc)2
(the processed zinc powder of dilute hydrochloric acid and copper acetate are placed in ice vinegar in the glacial acetic acid mixture of (containing two molecular crystalline water, 1.2mmol)
Stirred in acid, until rufous occurs in system), system is highly exothermic, and overnight, TLC monitoring display raw material is completely anti-for room temperature reaction
It answers, solvent is removed under vacuum, obtained solid is washed through ethyl acetate, and NaOH saturated solution adjusts pH=9 or so, ethyl acetate extraction
Water intaking phase merges organic phase, and anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of IV-4.
The crude product of gained IV-4 is dissolved in methylene chloride (20mL), is added triethylamine (15mmol) and (Boc)2O
(13mmol) reacts at room temperature 2h, and TLC monitoring raw material point completely disappears, and saturated ammonium chloride quenching reaction, ethyl acetate extraction is added
It takes, anhydrous magnesium sulfate is dry, filters and removes solid, and solvent is removed under vacuum, and column chromatographs (petroleum ether: ethyl acetate=30:1) and obtains
The total 4.1g of alkene V-4 is colorless viscous shape liquid, yield 61%.Structural identification:
1H NMR (300MHz, DMSO, 353K) δ 7.32-7.26 (m, 15H), 5.74-5.69 (m, 1H), 5.04-4.51
(m, 6H), 4.51 (s, 2H), 4.26 (d, J=4.0Hz, 1H), 4.17 (d, J=6.2Hz, 2H), 3.92 (d, J=3.1Hz,
1H), 3.64 (d, J=6.7Hz, 2H), 2.14-1.95 (m, 2H), 1.78 (s, 1H), 1.45 (s, 9H), 1.39-1.16 (m,
3H);13C NMR(75MHz,DMSO,353K)δ152.01,137.72,137.40,137.36,137.04,126.76-125.69,
113.29,79.51,77.53,76.42,71.04,70.67,70.38,68.54,60.72,56.38,31.61,30.38,
26.91,23.96。
Alkene V-4 (2.4mmol) is dissolved in 10mL in the mixed solvent, palladium acetate (0.96mmol) and copper acetate (band is added
The crystallization water, 4.8mmol), it is reacted at room temperature 4 days under oxygen atmosphere, TLC monitors fully reacting, and saturated ammonium chloride is added and is quenched instead
It answers, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, and solvent is removed under vacuum, and column chromatographs (petroleum ether: acetic acid
Ethyl ester=10:1) VI-4 crude product.
Under condition of ice bath, the crude product (in terms of 2mmol) of substrate VI-4 is dissolved in the methanol of 15mL, hydroboration is slowly added to
Sodium (2.5mmol) adds rear system into light gray, and TLC monitoring raw material point disappears after 30min, and saturated ammonium chloride is added and is quenched instead
It answers, methanol is removed under vacuum, the thick white oil object of gained is redissolved in saturated ammonium chloride, ethyl acetate extraction, anhydrous
Magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of VII-4.
The crude product of gained VII-4 is redissolved in 5mL dry methylene chloride, is added triethylamine (3mmol), condition of ice bath
Under be slowly added to methylsufonyl chloride (2.4mmol), add and move back except ice bath, react at room temperature 1h, TLC monitors raw material point and disappears, adds
Entering saturated ammonium chloride quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, and it filters and removes solid, remove solvent under vacuum,
Obtain the crude product of VIII-4.
The crude product of gained VIII-4 is redissolved in 5mL methylene chloride, and 3mL trifluoroacetic acid is added, and after reacting 1h, TLC is aobvious
Show that raw material disappears, saturation NaHCO is added3Quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, very
Sky is lower to remove solvent, obtains the crude product of IX-4.
The crude product of IX-4 is redissolved in 10mL methanol, addition 100mg Anhydrous potassium carbonate, room temperature reaction 48h, under vacuum
Methanol is removed, the thick grease of gained is redissolved in saturated ammonium chloride, and ethyl acetate extraction, anhydrous magnesium sulfate is dry, takes out
Solid is filtered out, solvent is removed under vacuum, column chromatography (petroleum ether: ethyl acetate=15:1) obtains the lesser point (XIV- of polarity
4a) 264mg and biggish point (XIV-4b) 256mg of polarity.Structural identification:
XIV-4a:1:[α]D 20=+24.0 (c 1.0, CH2Cl2);IR(cm-1):3090,3065,3030,2926,
2857,1496,1455,1370,1313,1097,734,699;1H NMR(300MHz,CDCl3)δ7.43–7.16(m,15H),
4.82-4.42 (m, 6H), 4.03-3.95 (m, 1H), 3.93-3.78 (m, 2H), 3.73 (dd, J=9.3,2.3Hz, 1H), 3.57
(dd, J=7.2,4.9Hz, 1H), 2.77-2.64 (m, 1H), 2.61-2.47 (m, 1H), 1.85 (d, J=10.4Hz, 1H),
1.69 (d, J=12.7Hz, 1H), 1.57 (d, J=9.0Hz, 2H), 1.41-1.21 (m, 2H), 1.17 (d, J=6.0Hz, 3H),
1.15–0.95(m,2H);13C NMR(75MHz,CDCl3)δ138.93,138.90,138.59,128.36-127.36,80.47,
77.71,77.58,77.16,76.74,73.46,72.60,72.28,66.35,64.81,59.72,53.02,34.80,
30.97,24.59,20.77。
XIV-4b:1H NMR(300MHz,CDCl3)δ7.40–7.13(m,15H),4.74–4.41(m,6H),4.18(dd,J
=6.5,5.1Hz, 1H), 3.94-3.84 (m, 1H), 3.65 (dd, J=6.9,5.0Hz, 1H), 3.54 (dd, J=9.1,
5.4Hz, 1H), 3.42-3.24 (m, 2H), 2.66 (dd, J=7.9,5.1Hz, 1H), 1.68-1.36 (m, 4H), 1.34-1.13
(m, 2H), 1.07 (d, J=6.4Hz, 3H)13C NMR(75MHz,CDCl3)δ139.05,138.75,138.70,128.35-
127.35,79.68,77.07,73.36,73.34,72.22,71.09,64.65,57.50,53.46,30.83,25.59,
20.94,18.98。
Substrate XIV-4a (200mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, 0.5mL is added
3N hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, palladium carbon is filtered to remove by diatomite, under vacuum
Solvent is removed, neutralizes by ammonium hydroxide, is handled by acidic resins column, obtains the total 72mg of I-4a, yield 85% is light yellow liquid
Body.Structural identification:
1H NMR(300MHz,D2O) δ 4.21 (t, J=7.5Hz, 1H), 3.86-3.75 (m, 2H), 3.68 (t, J=
7.0Hz, 1H), 3.41 (dd, J=11.4,4.7Hz, 1H), 2.72 (d, J=7.0Hz, 1H), 2.59-2.54 (m, 1H), 1.87
(d, J=12.7Hz, 1H), 1.71-1.59 (m, 2H), 1.33-1.17 (m, 1H), 1.11-0.94 (m, 2H), 2.72 (d, J=
6.2Hz,3H);13C NMR(75MHz,D2O)δ73.45,68.72,66.41,60.93,56.17,52.45,32.94,28.86,
23.32,18.88。
Substrate XIV-4b (200mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, 0.5mL is added
3N hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, palladium carbon is filtered to remove by diatomite, under vacuum
Solvent is removed, neutralizes by ammonium hydroxide, is handled by acidic resins column, obtains the total 76mg of I-4b, yield 89% is light yellow liquid
Body.Structural identification:
1H NMR(300MHz,D2O) δ 4.32 (s, 1H), 4.02 (dd, J=20.9,7.3Hz, 1H), 3.94-3.64 (m,
2H), 3.57 (d, J=5.9Hz, 1H), 3.32 (s, 1H), 3.05 (s, 1H), 2.59 (s, 1H), 1.79-1.50 (m, 4H),
1.55-1.19 (m, 3H), 1.19-1.06 (m, 1H), 1.01 (d, J=5.6Hz, 3H);13C NMR(75MHz,D2O)δ70.32,
69.57,66.65,59.98,58.85,55.57,31.56,22.47,19.87,17.69。
Embodiment 5: prepare Indolizidine class iminosugar I-5a, I-5b and its intermediate
It is bromo- that 5- is added under argon gas protection, in the tetrahydrofuran of steaming again (15mL) suspension for the magnesium chips (24mmol) newly polished
1- amylene (17mmol) is heated to 50 DEG C of reactions, and a large amount of bubbles occurs in system, and solution is in Dark grey, and the reaction was continued half an hour.It will
Nitrone II-5 (12mmol) is dissolved in dry tetrahydrofuran, under condition of ice bath, dropwise by syringe by above-mentioned Grignard Reagent
It is added, adds within 15 minutes, the reaction was continued 1h, TLC monitoring display raw material disappearance, addition saturated ammonium chloride solution quenching reaction, second
Acetoacetic ester extraction, without drying, directly removes solvent under vacuum, obtains the crude product of III-5.
The crude product of III-5 is dissolved in acetic acid, preactivated good zinc powder (0.12mol) and Cu (OAc) are added to2(contain
Two molecular crystalline water, 1.2mmol) glacial acetic acid mixture in (the processed zinc powder of dilute hydrochloric acid and copper acetate are placed in glacial acetic acid
Middle stirring, until rufous occurs in system), system is highly exothermic, and overnight, TLC monitoring display raw material reacts completely for room temperature reaction,
Solvent is removed under vacuum, obtained solid is washed through ethyl acetate, and NaOH saturated solution adjusts pH=9 or so, ethyl acetate extraction
Water phase merges organic phase, and anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of IV-5.
The crude product of gained IV-5 is dissolved in methylene chloride (20mL), is added triethylamine (15mmol) and (Boc)2O
(13mmol) reacts at room temperature 2h, and TLC monitoring raw material point completely disappears, and saturated ammonium chloride quenching reaction, ethyl acetate extraction is added
Take, anhydrous magnesium sulfate is dry, filters and removes solid, remove solvent under vacuum, column chromatograph colorless viscous shape liquid V-5 is total
3.1g, yield 65%.Structural identification:
1H NMR(400MHz,CDCl3) δ 7.45-7.13 (m, 10H), 5.86-5.75 (m, 1H), 5.00 (t, J=
13.7Hz, 2H), 4.66-4.43 (m, 4H), 4.05 (s, 1H), 3.87 (d, J=10.7Hz, 2H), 3.75 (s, 1H), 3.45 (d,
J=11.9Hz, 1H), 2.08-2.01m, 2H), 1.96-1.52 (m, 3H), 1.52-1.20 (m, 11H)13C NMR(75MHz,
CDCl3)δ154.63,138.57,137.88,137.80,128.51,127.88,127.85,127.72,127.65,114.69,
85.15,83.32,81.88,80.81,79.45,71.60,71.32,62.53,50.94,50.01,33.60,31.76,
31.18,28.55,25.89,25.53。
Substrate V-5 (2.4mmol) is dissolved in 10mL in the mixed solvent, palladium acetate (0.96mmol) and copper acetate (band is added
The crystallization water, 4.8mmol), it is reacted at room temperature 4 days under oxygen atmosphere, TLC monitors fully reacting, and saturated ammonium chloride is added and is quenched instead
It answers, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, and solvent is removed under vacuum, and column chromatographs (petroleum ether: acetic acid
Ethyl ester=10:1) VI-5 crude product.
Under condition of ice bath, the crude product (in terms of 2mmol) of substrate VI-5 is dissolved in the methanol of 15mL, hydroboration is slowly added to
Sodium (2.5mmol) adds rear system into light gray, and TLC monitoring raw material point disappears after 30min, and saturated ammonium chloride is added and is quenched instead
It answers, methanol is removed under vacuum, the thick white oil object of gained is redissolved in saturated ammonium chloride, ethyl acetate extraction, anhydrous
Magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of VII-5.
The crude product of VII-5 is redissolved in 5mL dry methylene chloride, is added triethylamine (3mmol), is delayed under condition of ice bath
It is slow that methylsufonyl chloride (2.4mmol) is added, it adds and moves back except ice bath, react at room temperature 1h, TLC monitors raw material point and disappears, and is added full
With ammonium chloride quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain
The crude product of VIII-5.
The crude product of VIII-5 is dissolved in 5mL methylene chloride, 3mL trifluoroacetic acid is added, after reacting 1h, TLC shows raw material
It disappears, saturation NaHCO is added3Quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, removes under vacuum
Solvent is removed, the crude product of IX-5 is obtained.
The crude product of IX-5 is redissolved in 10mL methanol, addition 100mg Anhydrous potassium carbonate, room temperature reaction 48h, under vacuum
Methanol is removed, the thick grease of gained is redissolved in saturated ammonium chloride, and ethyl acetate extraction, anhydrous magnesium sulfate is dry, takes out
Solid is filtered out, solvent is removed under vacuum, column chromatography (petroleum ether: ethyl acetate=15:1) obtains the lesser point (XIV- of polarity
5a) the total 129mg and polarity total 115mg of biggish point (XIV-5b), structural identification:
XIV-5a:1H NMR(400MHz,CDCl3)δ7.41–7.27(m,10H),4.65–4.46(m,4H),3.98–3.92
(m, 1H), 3.79 (dd, J=8.2,2.8Hz, 1H), 3.33 (d, J=10.4Hz, 1H), 2.37 (dd, J=10.4,6.6Hz,
1H), 2.03 (dd, J=13.5,5.5Hz, 3H), 1.80-1.78 (m, 1H), 1.58-1.56 (m, 1H), 1.41-1.24 (m,
3H), 1.12 (d, J=6.2Hz, 3H);13C NMR(101MHz,CDCl3)δ138.37,138.32,128.3-127.63,
89.70,81.85,72.21,71.34,68.50,58.93,56.42,33.67,29.29,24.29,20.49.
XIV-5a:1H NMR(400MHz,CDCl3)δ7.42–7.31(m,10H),4.67–4.48(m,4H),3.95–3.93
(m, 1H), 3.71 (dd, J=7.2,2.5Hz, 1H), 3.26-3.23 (m, 1H), 2.95-2.87 (m, 2H), 2.58-2.52 (m,
1H), 2.01-1.97 (m, 1H), 1.88-1.81 (m, 1H), 1.68-1.32 (m, 5H), 1.00 (d, J=6.6Hz, 3H);13C
NMR(101MHz,CDCl3)δ138.39,138.32,128.38-127.64,90.57,82.34,72.15,71.40,59.54,
53.81,50.13,30.87,29.95,18.82,9.33。
Substrate XIV-5a (100mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, 0.5mL is added
3N hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, palladium carbon is filtered to remove by diatomite, under vacuum
Solvent is removed, neutralizes by ammonium hydroxide, is handled by acidic resins column, obtain the total 42mg of I-5a, white solid, yield 88%.Knot
Structure confirmation:
1H NMR(400MHz,D2O) δ 3.97 (ddd, J=7.7,4.2,1.8Hz, 1H), 3.55 (dd, J=9.1,4.3Hz,
1H), 2.90 (dd, J=11.3,1.4Hz, 1H), 2.54 (dd, J=11.2,8.0Hz, 1H), 2.13-2.05 (m, 1H), 1.98-
1.93 (m, 1H), 1.81 (d, J=13.8Hz, 1H), 1.73-1.68 (m, 1.60-1.49 (m, 1H), 1.29-1.01 (m, 3H),
0.94 (d, J=6.3Hz, 3H);13C NMR(101MHz,D2O)δ82.36,75.08,68.60,58.85,57.77,32.46,
27.13,23.23,18.73。
Substrate XIV-5b (100mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, 0.5mL is added
3N hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, palladium carbon is filtered to remove by diatomite, under vacuum
Solvent is removed, neutralizes by ammonium hydroxide, is handled by acidic resins column, obtain faint yellow solid 46mg, yield 96%.Structure is true
Card:
1H NMR(400MHz,D2O) δ 3.96 (s, 1H), 3.63 (dd, J=8.1,3.9Hz, 1H), 3.06-2.97 (m,
2H), 2.60 (d, J=11.7Hz, 1H), 2.56-2.52 (m, 1H), 1.75-1.72 (m, 1H), 1.59-1.54 (m, 1H),
1.47-1.39 (m, 2H), 1.34-1.25 (m, 2H), 0.91 (d, J=6.3Hz, 3H)13C NMR(101MHz,D2O)δ81.53,
75.54,60.62,54.86,51.25,29.88,26.47,17.46,10.95。
Embodiment 6: prepare Indolizidine class iminosugar I-6a, I-6b and its intermediate
It is bromo- that 5- is added under argon gas protection, in the tetrahydrofuran of steaming again (15mL) suspension for the magnesium chips (24mmol) newly polished
1- amylene (17mmol) is heated to 50 DEG C of reactions, and a large amount of bubbles occurs in system, and solution is in Dark grey, and the reaction was continued half an hour.It will
Nitrone II-4 (12mmol) is dissolved in dry tetrahydrofuran, under condition of ice bath, dropwise by syringe by above-mentioned Grignard Reagent
It is added, adds within 15 minutes, the reaction was continued 1h, TLC monitoring display raw material disappearance, addition saturated ammonium chloride solution quenching reaction, second
Acetoacetic ester extraction, without drying, directly removes solvent under vacuum, obtains the crude product of III-4.
The crude product of gained III-4 is dissolved in acetic acid, is added to preactivated good zinc powder (0.12mol) and Cu (OAc)2
(the processed zinc powder of dilute hydrochloric acid and copper acetate are placed in ice vinegar in the glacial acetic acid mixture of (containing two molecular crystalline water, 1.2mmol)
Stirred in acid, until rufous occurs in system), system is highly exothermic, and overnight, TLC monitoring display raw material is completely anti-for room temperature reaction
It answers, solvent is removed under vacuum, obtained solid is washed through ethyl acetate, and NaOH saturated solution adjusts pH=9 or so, ethyl acetate extraction
Water intaking phase merges organic phase, and anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of IV-4.
The crude product of gained IV-4 is dissolved in methylene chloride (20mL), is added triethylamine (15mmol) and (Boc)2O
(13mmol) reacts at room temperature 2h, and TLC monitoring raw material point completely disappears, and saturated ammonium chloride quenching reaction, ethyl acetate extraction is added
It takes, anhydrous magnesium sulfate is dry, filters and removes solid, and solvent is removed under vacuum, and column chromatographs (petroleum ether: ethyl acetate=30:1) and obtains
The total 4.1g of V-4 is colorless viscous shape liquid, yield 61%.Structural identification:
1H NMR (300MHz, DMSO, 353K) δ 7.32-7.26 (m, 15H), 5.74-5.69 (m, 1H), 5.04-4.51
(m, 6H), 4.51 (s, 2H), 4.26 (d, J=4.0Hz, 1H), 4.17 (d, J=6.2Hz, 2H), 3.92 (d, J=3.1Hz,
1H), 3.64 (d, J=6.7Hz, 2H), 2.14-1.95 (m, 2H), 1.78 (s, 1H), 1.45 (s, 9H), 1.39-1.16 (m,
3H);13C NMR(75MHz,DMSO,353K)δ152.01,137.72,137.40,137.36,137.04,126.76-125.69,
113.29,79.51,77.53,76.42,71.04,70.67,70.38,68.54,60.72,56.38,31.61,30.38,
26.91,23.96。
V-4 (1.4mmol) is dissolved in Isosorbide-5-Nitrae-dioxane (5mL), 1mL water is added, sequentially adds sodium metaperiodate
It is small to stir 12 at room temperature for (5.6mmol), 2,6- lutidines (2.8mmol) and 1 weight % osmium tetroxide aqueous solution (1mL)
When, saturated aqueous sodium thiosulfate quenching reaction is added, filters away the solid generated, ethyl acetate extraction, anhydrous slufuric acid
Magnesium is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of X-1.
Under argon gas protection, 1- bromine fourth is added in the tetrahydrofuran of steaming again (2mL) suspension for the magnesium chips (4.2mmol) newly polished
Alkane (2.8mmol) is heated to 50 DEG C of reactions, and a large amount of bubbles occurs in system, and solution is in Dark grey, and the reaction was continued half an hour.By X-1
Crude product (in terms of 1.4mmol) be dissolved in dry tetrahydrofuran, under condition of ice bath, by above-mentioned Grignard Reagent by syringe by
It is added dropwise to, continues to reflect 10h, TLC monitoring) display raw material disappearance, saturated ammonium chloride solution quenching reaction, ethyl acetate extraction is added
It takes, without drying, directly removes solvent under vacuum, obtain the crude product of XI-1.
The crude product of gained XI-1 is redissolved in 5mL dry methylene chloride, is added triethylamine (3mmol), condition of ice bath
Under be slowly added to methylsufonyl chloride (2.4mmol), add and move back except ice bath, react at room temperature 1h, TLC monitors raw material point and disappears, adds
Entering saturated ammonium chloride quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, and it filters and removes solid, remove solvent under vacuum,
Obtain the crude product of XII-1.
The crude product of gained XII-1 is redissolved in 5mL methylene chloride, and 3mL trifluoroacetic acid is added, and after reacting 1h, TLC is shown
Raw material disappears, and saturation NaHCO is added3Quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, vacuum
Lower removing solvent, obtains the crude product of XIII-1.
The crude product of XIII-1 is redissolved in 10mL methanol, 100mg Anhydrous potassium carbonate is added, reacts at room temperature 48h, vacuum
Lower removing methanol, the thick grease of gained are redissolved in saturated ammonium chloride, and ethyl acetate extraction, anhydrous magnesium sulfate is dry,
It filters and removes solid, solvent is removed under vacuum, column chromatography (petroleum ether: ethyl acetate=15:1) obtains the lesser point of polarity
(XIV-6a) the total 161mg and total 190mg of the biggish point (XIV-6b) of polarity.Structural identification:
XIV-6a:1H NMR(400MHz,CDCl3)δ7.44–7.16(m,16H),4.81–4.40(m,6H),4.01–3.92
(m, 1H), 3.90-3.79 (m, 2H), 3.74 (t, J=6.3Hz, 1H), 3.57 (dd, J=7.2,4.9Hz, 1H), 2.59-2.48
(m, 2H), 1.94 (d, J=13.0Hz, 1H), 1.84 (d, J=11.6Hz, 1H), 1.71 (d, J=11.3Hz, 2H), 1.42-
0.87 (m, 11H), 0.85 (t, J=7.0Hz, 3H);13C NMR(101MHz,CDCl3)δ139.03,138.91,138.71,
128.41,128.35,128.31,127.90,127.69,127.67,127.58,127.53,127.44,80.63,77.84,
73.58,72.69,72.37,66.62,64.80,59.26,57.77,33.36,31.22,31.12,27.88,24.57,
23.28,14.30。
XIV-6b:1H NMR(400MHz,CDCl3)δ7.44–7.23(m,16H),4.74–4.45(m,6H),4.27(dd,J
=7.6,5.0Hz, 1H), 3.95 (dd, J=9.1,7.0Hz, 1H), 3.69 (t, J=4.5Hz, 1H), 3.56 (dd, J=9.2,
5.2Hz,1H),3.46–3.29(m,2H),2.70(s,1H),1.70–1.49(m,3H),1.49–1.13(m,11H),0.92(t,
J=6.8Hz, 3H);13C NMR(101MHz,CDCl3)δ139.09,139.03,138.93,128.36,128.33,127.82,
127.78,127.57,127.49,127.42,77.71,73.39,72.94,62.95,56.90,56.25,32.80,29.00,
26.57,25.77,23.07,18.88,14.34。
Substrate XIV-6a (100mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, 0.5mL is added
3N hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, palladium carbon is filtered to remove by diatomite, under vacuum
Solvent is removed, neutralizes by ammonium hydroxide, is handled by acidic resins column, obtain the total 44mg of I-6a, colorless oil, yield 94%.
Structural identification:
1H NMR (400MHz, MeOD) δ 4.52 (t, J=7.2Hz, 1H), 4.01 (d, J=9.8Hz, 1H), 3.92 (dd, J
=12.2,4.3Hz, 3H), 3.36-3.31 (m, 1H), 3.20 (t, J=10.3Hz, 1H), 2.03 (d, J=13.0Hz, 2H),
1.99-1.83 (m, 2H), 1.61-1.25 (m, 9H), 0.96 (t, J=6.8Hz, 3H);13C NMR(101MHz,MeOD)δ
72.57,68.70,68.10,61.51,60.16,56.11,31.96,27.69,27.52,26.41,22.37,22.32,
12.95。
Substrate XIV-6b (100mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, 0.5mL is added
3N hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, palladium carbon is filtered to remove by diatomite, under vacuum
Solvent is removed, neutralizes by ammonium hydroxide, is handled by acidic resins column, obtain faint yellow solid 45mg, yield 97%.Structure is true
Card:
1H NMR(400MHz,MeOD)δ4.50(s,1H),4.18(s,1H),3.90-3.87(m,2H),3.83(s,1H),
(3.58 d, J=5.1Hz, 1H), 3.33 (s, 1H), 2.08-1.93 (m, 2H), 1.91-1.25 (m, 11H), 0.97 (t, J=
6.7Hz,3H);13C NMR(101MHz,MeOD)δ70.44,68.86,67.75,60.89,59.86,57.93,30.81,
27.65,25.70,22.23,22.16,16.48,12.89。
Embodiment 7: prepare Indolizidine class iminosugar I-7a, I-7b and its intermediate
It is bromo- that 5- is added under argon gas protection, in the tetrahydrofuran of steaming again (15mL) suspension for the magnesium chips (24mmol) newly polished
1- amylene (17mmol) is heated to 50 DEG C of reactions, and a large amount of bubbles occurs in system, and solution is in Dark grey, and the reaction was continued half an hour.It will
Nitrone II-4 (12mmol) is dissolved in dry tetrahydrofuran, under condition of ice bath, dropwise by syringe by above-mentioned Grignard Reagent
It is added, adds within 15 minutes, the reaction was continued 1h, TLC monitoring display raw material disappearance, addition saturated ammonium chloride solution quenching reaction, second
Acetoacetic ester extraction, without drying, directly removes solvent under vacuum, obtains the crude product of III-4.
The crude product of gained III-4 is dissolved in acetic acid, is added to preactivated good zinc powder (0.12mol) and Cu (OAc)2
(the processed zinc powder of dilute hydrochloric acid and copper acetate are placed in ice vinegar in the glacial acetic acid mixture of (containing two molecular crystalline water, 1.2mmol)
Stirred in acid, until rufous occurs in system), system is highly exothermic, and overnight, TLC monitoring display raw material is completely anti-for room temperature reaction
It answers, solvent is removed under vacuum, obtained solid is washed through ethyl acetate, and NaOH saturated solution adjusts pH=9 or so, ethyl acetate extraction
Water intaking phase merges organic phase, and anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of IV-4.
The crude product of gained IV-4 is dissolved in methylene chloride (20mL), is added triethylamine (15mmol) and (Boc)2O
(13mmol) reacts at room temperature 2h, and TLC monitoring raw material point completely disappears, and saturated ammonium chloride quenching reaction, ethyl acetate extraction is added
It takes, anhydrous magnesium sulfate is dry, filters and removes solid, and solvent is removed under vacuum, and column chromatographs (petroleum ether: ethyl acetate=30:1) and obtains
V-44.1g is colorless viscous shape liquid, yield 61%.Structural identification:
1H NMR (300MHz, DMSO, 353K) δ 7.32-7.26 (m, 15H), 5.74-5.69 (m, 1H), 5.04-4.51
(m, 6H), 4.51 (s, 2H), 4.26 (d, J=4.0Hz, 1H), 4.17 (d, J=6.2Hz, 2H), 3.92 (d, J=3.1Hz,
1H), 3.64 (d, J=6.7Hz, 2H), 2.14-1.95 (m, 2H), 1.78 (s, 1H), 1.45 (s, 9H), 1.39-1.16 (m,
3H);13C NMR(75MHz,DMSO,353K)δ152.01,137.72,137.40,137.36,137.04,126.76-125.69,
113.29,79.51,77.53,76.42,71.04,70.67,70.38,68.54,60.72,56.38,31.61,30.38,
26.91,23.96。
V-4 (1.4mmol) is dissolved in Isosorbide-5-Nitrae-dioxane (5mL), 1mL water is added, sequentially adds sodium metaperiodate
(5.6mmol), 2,6- lutidines (2.8mmol) and 1 weight % osmium tetroxide aqueous solution (1mL), stir 12h at room temperature,
Saturated aqueous sodium thiosulfate quenching reaction is added, filters away the solid generated, ethyl acetate extraction, anhydrous magnesium sulfate is done
It is dry, it filters and removes solid, remove solvent under vacuum, obtain the crude product of X-1.
Under argon gas protection, 1- bromine nonyl is added in the tetrahydrofuran of steaming again (2mL) suspension for the magnesium chips (4.2mmol) newly polished
Alkane (2.8mmol) is heated to 50 DEG C of reactions, and a large amount of bubbles occurs in system, and solution is in Dark grey, and the reaction was continued half an hour.By X-1
Crude product (in terms of 1.4mmol) be dissolved in dry tetrahydrofuran, under condition of ice bath, by above-mentioned Grignard Reagent by syringe by
It is added dropwise to, the reaction was continued 10h, TLC monitoring display raw material disappearance, addition saturated ammonium chloride solution quenching reaction, ethyl acetate extraction
It takes, without drying, directly removes solvent under vacuum, obtain the crude product of XI-2.
The crude product of gained XI-2 is redissolved in 5mL dry methylene chloride, is added triethylamine (3mmol), condition of ice bath
Under be slowly added to methylsufonyl chloride (2.4mmol), add and move back except ice bath, react at room temperature 1h, TLC monitors raw material point and disappears, adds
Entering saturated ammonium chloride quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, and it filters and removes solid, remove solvent under vacuum,
Obtain the crude product of XII-2.
The crude product of gained XII-2 is redissolved in 5mL methylene chloride, and 3mL trifluoroacetic acid is added, and after reacting 1h, TLC is shown
Raw material disappears, and saturation NaHCO is added3Quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, vacuum
Lower removing solvent, obtains the crude product of XIII-2.
The crude product of XIII-2 is redissolved in 10mL methanol, 100mg Anhydrous potassium carbonate is added, reacts at room temperature 48h, vacuum
Lower removing methanol, the thick grease of gained are redissolved in saturated ammonium chloride, and ethyl acetate extraction, anhydrous magnesium sulfate is dry,
It filters and removes solid, solvent is removed under vacuum, column chromatography (petroleum ether: ethyl acetate=15:1) obtains the lesser point of polarity
(XIV-7a) the total 261mg and total 237mg of the biggish point (XIV-7b) of polarity.Structural identification:
XIV-7a:1H NMR(400MHz,CDCl3)δ7.39–7.16(m,16H),4.82–4.41(m,6H),4.02–3.92
(m, 1H), 3.91-3.81 (m, 2H), 3.73 (q, J=6.3Hz, 1H), 3.56 (dd, J=7.2,4.9Hz, 1H), 2.60-2.48
(m, 2H), 1.95 (dd, J=16.1,6.5Hz, 1H), 1.84 (d, J=11.5Hz, 1H), 1.71 (d, J=11.0Hz, 2H),
1.39-0.91 (m, 21H), 0.88 (t, J=6.8Hz, 3H);13C NMR(101MHz,CDCl3)δ128.31,128.25,
128.21,127.80,127.56,127.48,127.44,127.34,80.50,77.71,73.47,72.58,72.25,
70.22,66.52,64.70,59.15,57.70,37.36,33.56,31.98,31.85,31.11,31.01,30.20,
29.80,29.70,29.42,29.21,29.16,29.06,25.60,25.45,24.47,22.74,22.68,14.18,
14.14。
XIV-7b:1H NMR(400MHz,CDCl3)δ7.44–7.17(m,16H),4.72–4.42(m,6H),4.26–4.20
(m, 1H), 3.91 (dd, J=9.1,7.1Hz, 1H), 3.65 (t, J=4.5Hz, 1H), 3.51 (dd, J=9.1,5.2Hz, 1H),
3.39-3.29 (m, 2H), 2.65 (s, 1H), 1.69-1.12 (m, 27H), 0.88 (t, J=6.8Hz, 3H);13C NMR
(101MHz,CDCl3)δ138.99,138.92,138.82,128.27,128.25,127.72,127.69,127.47,
127.41,127.34,127.31,80.53,77.57,73.30,72.85,72.01,71.83,62.90,56.80,56.24,
33.05,31.97,29.98,29.82,29.71,29.44,26.69,26.44,25.73,22.75,18.79,14.19。
XIV-7a (100mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, the 3N of 0.5mL is added
Hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, is filtered to remove palladium carbon by diatomite, removes under vacuum
Solvent is neutralized by ammonium hydroxide, is handled by acidic resins column, and the total 49mg of I-7a, colorless oil, yield 91% are obtained.
1H NMR (400MHz, MeOD) δ 4.35 (t, J=7.2Hz, 1H), 3.88 (d, J=3.3Hz, 2H), 3.76 (t, J
=6.1Hz, 1H), 3.67-3.59 (m, 1H), 2.93 (d, J=10.1Hz, 1H), 2.87 (t, J=9.9Hz, 1H), 1.96 (d, J
=12.1Hz, 1H), 1.86 (dd, J=21.4,12.0Hz, 3H), 1.53-1.08 (m, 20H), 0.90 (t, J=6.6Hz, 3H)
;13C NMR(101MHz,MeOD)δ73.46,69.08,67.57,61.23,58.41,56.64,32.76,31.67,29.53,
29.34,29.30,29.18,29.06,28.30,25.41,23.22,22.35,13.09。
Substrate XIV-7b (100mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, 0.5mL is added
3N hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, palladium carbon is filtered to remove by diatomite, under vacuum
Solvent is removed, neutralizes by ammonium hydroxide, is handled by acidic resins column, obtain faint yellow solid 45mg, yield 97%.
1H NMR (500MHz, MeOD) δ 4.50 (s, 1H), 4.22 (dd, J=7.6,4.9Hz, 1H), 3.95-3.85 (m,
3H), 3.64 (dd, J=12.7,5.5Hz, 1H), 3.25-3.15 (m, 1H), 2.10-1.96 (m, 2H), 1.94-1.79 (m,
2H), 1.79-1.49 (m, 5H), 1.48-1.23 (m, 16H), 0.92 (t, J=6.9Hz, 3H);13C NMR(126MHz,MeOD)δ
69.98,68.55,68.42,61.10,60.60,57.76,31.65,30.90,29.24,29.19,29.16,29.03,
25.85,25.33,22.33,21.72,16.19,13.05。
Embodiment 8: prepare Indolizidine class iminosugar I-8a, I-8b and its intermediate
It is bromo- that 5- is added under argon gas protection, in the tetrahydrofuran of steaming again (15mL) suspension for the magnesium chips (24mmol) newly polished
1- amylene (17mmol) is heated to 50 DEG C of reactions, and a large amount of bubbles occurs in system, and solution is in Dark grey, and the reaction was continued half an hour.It will
Nitrone II-6 (12mmol) is dissolved in dry tetrahydrofuran, under condition of ice bath, dropwise by syringe by above-mentioned Grignard Reagent
It is added, adds within 15 minutes, the reaction was continued 1h, TLC monitoring display raw material disappearance, addition saturated ammonium chloride solution quenching reaction, second
Acetoacetic ester extraction, without drying, directly removes solvent under vacuum, obtains the crude product of III-6.
The crude product of gained III-6 is dissolved in acetic acid, is added to preactivated good zinc powder (0.12mol) and Cu (OAc)2
(the processed zinc powder of dilute hydrochloric acid and copper acetate are placed in ice vinegar in the glacial acetic acid mixture of (containing two molecular crystalline water, 1.2mmol)
Stirred in acid, until rufous occurs in system), system is highly exothermic, and overnight, TLC monitoring display raw material is completely anti-for room temperature reaction
It answers, solvent is removed under vacuum, obtained solid is washed through ethyl acetate, and NaOH saturated solution adjusts pH=9 or so, ethyl acetate extraction
Water intaking phase merges organic phase, and anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of IV-6.
The crude product of gained IV-6 is dissolved in methylene chloride (20mL), is added triethylamine (15mmol) and (Boc)2O
(13mmol) reacts at room temperature 2h, and TLC monitoring raw material point completely disappears, and saturated ammonium chloride quenching reaction, ethyl acetate extraction is added
It takes, anhydrous magnesium sulfate is dry, filters and removes solid, and solvent is removed under vacuum, and column chromatographs (petroleum ether: ethyl acetate=30:1) and obtains
V-6 (4.1g is colorless viscous shape liquid), yield 61%.Structural identification:
1H NMR (300MHz, DMSO, 353K) δ 7.32-7.26 (m, 15H), 5.74-5.69 (m, 1H), 5.04-4.51
(m, 6H), 4.51 (s, 2H), 4.26 (d, J=4.0Hz, 1H), 4.17 (d, J=6.2Hz, 2H), 3.92 (d, J=3.1Hz,
1H), 3.64 (d, J=6.7Hz, 2H), 2.14-1.95 (m, 2H), 1.78 (s, 1H), 1.45 (s, 9H), 1.39-1.16 (m,
3H);13C NMR(75MHz,DMSO,353K)δ152.01,137.72,137.40,137.36,137.04,126.76-125.69,
113.29,79.51,77.53,76.42,71.04,70.67,70.38,68.54,60.72,56.38,31.61,30.38,
26.91,23.96。
V-6 (1.4mmol) is dissolved in Isosorbide-5-Nitrae-dioxane (5mL), 1mL water is added, sequentially adds sodium metaperiodate
It is small to stir 12 at room temperature for (5.6mmol), 2,6- lutidines (2.8mmol) and 1 weight % osmium tetroxide aqueous solution (1mL)
When, saturated aqueous sodium thiosulfate quenching reaction is added, filters away the solid generated, ethyl acetate extraction, anhydrous slufuric acid
Magnesium is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of X-3.
Under argon gas protection, 1- bromine fourth is added in the tetrahydrofuran of steaming again (2mL) suspension for the magnesium chips (4.2mmol) newly polished
Alkane (2.8mmol) is heated to 50 DEG C of reactions, and a large amount of bubbles occurs in system, and solution is in Dark grey, and the reaction was continued half an hour.By X-3
Crude product (in terms of 1.4mmol) be dissolved in dry tetrahydrofuran, under condition of ice bath, by above-mentioned Grignard Reagent by syringe by
It is added dropwise to, the reaction was continued 10h, TLC monitoring display raw material disappearance, addition saturated ammonium chloride solution quenching reaction, ethyl acetate extraction
It takes, without drying, directly removes solvent under vacuum, obtain the crude product of XI-3.
The crude product of gained XI-3 is redissolved in 5mL dry methylene chloride, is added triethylamine (3mmol), condition of ice bath
Under be slowly added to methylsufonyl chloride (2.4mmol), add and move back except ice bath, react at room temperature 1h, TLC monitors raw material point and disappears, adds
Entering saturated ammonium chloride quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, and it filters and removes solid, remove solvent under vacuum,
Obtain the crude product of XII-3.
The crude product of gained XII-3 is redissolved in 5mL methylene chloride, and 3mL trifluoroacetic acid is added, and after reacting 1h, TLC is shown
Raw material disappears, and saturation NaHCO is added3Quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, vacuum
Lower removing solvent, obtains the crude product of XIII-3.
The crude product of XIII-3 is redissolved in 10mL methanol, 100mg Anhydrous potassium carbonate is added, reacts at room temperature 48h, vacuum
Lower removing methanol, the thick grease of gained are redissolved in saturated ammonium chloride, and ethyl acetate extraction, anhydrous magnesium sulfate is dry,
It filters and removes solid, solvent is removed under vacuum, column chromatography (petroleum ether: ethyl acetate=15:1) obtains the lesser point of polarity
(XIV-8a) the total 189mg and total 173mg of the biggish point (XIV-8b) of polarity.Structural identification:
XIV-8a:1H NMR(400MHz,CDCl3) δ 7.29 (dd, J=22.8,8.7Hz, 15H), 4.82-4.42 (m,
6H), 3.96 (d, J=6.3Hz, 1H), 3.86 (d, J=5.9Hz, 2H), 3.74 (t, J=6.0Hz, 1H), 3.60-3.51 (m,
1H), 2.54 (s, 2H), 1.95 (s, 1H), 1.84 (d, J=11.6Hz, 1H), 1.71 (d, J=11.2Hz, 2H), 1.35-0.88
(m, 9H), 0.85 (t, J=6.2Hz, 3H);13C NMR(101MHz,CDCl3)δ138.97,138.85,138.65,128.34,
128.28,128.23,127.82,127.62,127.59,127.50,127.45,127.36,80.58,77.79,73.51,
72.62,72.30,66.55,64.74,59.20,57.70,33.29,31.15,31.05,27.80,24.51,23.21,
14.24.
XIV-8b:1H NMR(400MHz,CDCl3)δ7.42–7.19(m,16H),4.74–4.43(m,6H),4.26–4.18
(m, 1H), 3.91 (t, J=7.9Hz, 1H), 3.65 (s, 1H), 3.51 (dd, J=8.8,5.2Hz, 1H), 3.41-3.28 (m,
2H), 2.66 (s, 1H), 1.70-1.06 (m, 13H), 0.87 (d, J=6.5Hz, 3H);13C NMR(101MHz,CDCl3)δ
139.02,138.96,138.86,128.55,128.28,128.25,127.74,127.70,127.59,127.49,127.42,
127.34,126.97,80.66,77.65,73.31,72.87,72.04,71.88,62.90,56.84,56.19,32.72,
28.93,26.50,25.71,22.99,18.82,14.26。
XIV-8a (100mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, the 3N of 0.5mL is added
Hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, is filtered to remove palladium carbon by diatomite, removes under vacuum
Solvent is neutralized by ammonium hydroxide, is handled by acidic resins column, and the total 44mg of I-8a, colorless oil, yield 94% are obtained.
1H NMR (400MHz, MeOD) δ 4.52 (t, J=7.1Hz, 1H), 4.01 (d, J=9.9Hz, 1H), 3.92 (dd, J
=12.1,4.2Hz, 3H), 3.33 (d, J=1.4Hz, 1H), 3.20 (t, J=10.3Hz, 1H), 2.03 (d, J=13.0Hz,
2H), 1.98-1.83 (m, 2H), 1.64-1.23 (m, 9H), 0.96 (t, J=6.7Hz, 3H);13C NMR(101MHz,MeOD)δ
72.57,68.70,68.09,61.51,60.16,56.11,31.96,27.69,27.51,26.41,22.38,22.32,
12.95。
XIV-8b (100mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, the 3N of 0.5mL is added
Hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, is filtered to remove palladium carbon by diatomite, removes under vacuum
Solvent is neutralized by ammonium hydroxide, is handled by acidic resins column, and faint yellow solid 45mg, yield 97% are obtained.
1H NMR(400MHz,MeOD)δ4.48(s,1H),4.16(s,1H),3.84(s,2H),3.81(s,1H),3.56
(d, J=5.2Hz, 1H), 3.18-3.03 (m, 1H), 2.08-1.91 (m, 2H), 1.87-1.59 (m, 5H), 1.59-1.21 (m,
8H), 0.94 (t, J=6.7Hz, 3H);13C NMR(101MHz,MeOD)δ70.43,68.85,67.76,60.89,59.87,
57.93,30.81,27.65,25.71,22.23,22.15,16.48,12.89。
Embodiment 9: prepare Indolizidine class iminosugar I-9a, I-9b and its intermediate
It is bromo- that 5- is added under argon gas protection, in the tetrahydrofuran of steaming again (15mL) suspension for the magnesium chips (24mmol) newly polished
1- amylene (17mmol) is heated to 50 DEG C of reactions, and a large amount of bubbles occurs in system, and solution is in Dark grey, and the reaction was continued half an hour.It will
Nitrone II-6 (12mmol) is dissolved in dry tetrahydrofuran, under condition of ice bath, dropwise by syringe by above-mentioned Grignard Reagent
It is added, adds within 15 minutes, the reaction was continued 1h, TLC monitoring (petroleum ether: ethyl acetate=1:1) display raw material disappearance, addition saturation
Ammonium chloride solution quenching reaction, ethyl acetate extraction, without drying, directly removes solvent under vacuum, obtains the thick of III-6
Product.
The crude product of gained III-6 is dissolved in acetic acid, is added to preactivated good zinc powder (0.12mol) and Cu (OAc)2
(the processed zinc powder of dilute hydrochloric acid and copper acetate are placed in ice vinegar in the glacial acetic acid mixture of (containing two molecular crystalline water, 1.2mmol)
Stirred in acid, until rufous occurs in system), system is highly exothermic, and overnight, TLC monitoring display raw material is completely anti-for room temperature reaction
It answers, solvent is removed under vacuum, obtained solid is washed through ethyl acetate, and NaOH saturated solution adjusts pH=9 or so, ethyl acetate extraction
Water intaking phase merges organic phase, and anhydrous magnesium sulfate is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of IV-6.
The crude product of gained IV-6 is dissolved in methylene chloride (20mL), is added triethylamine (15mmol) and (Boc)2O
(13mmol) reacts at room temperature 2h, and TLC monitoring raw material point completely disappears, and saturated ammonium chloride quenching reaction, ethyl acetate extraction is added
It takes, anhydrous magnesium sulfate is dry, filters and removes solid, and solvent is removed under vacuum, and column chromatographs (petroleum ether: ethyl acetate=30:1) and obtains
V-6 (4.1g is colorless viscous shape liquid), yield 61%.Structural identification:
1H NMR (300MHz, DMSO, 353K) δ 7.51-7.08 (m, 15H), 5.89-5.71 (m, 1H), 5.00 (t, J=
13.4Hz, 2H), 4.75 (t, J=10.6Hz, 1H), 4.71-4.56 (m, 3H), 4.51 (s, 2H), 4.27 (s, 1H), 4.18 (d,
J=6.2Hz, 2H), 3.92 (d, J=3.1Hz, 1H), 3.64 (d, J=6.7Hz, 2H), 1.45 (s, 9H), 1.40-1.14 (m,
4H).13C NMR(75MHz,DMSO,353K)δ151.99,137.70,137.39,137.35,137.03,126.77,126.63,
126.03,125.95,125.70,113.31,79.46,77.52,76.40,71.04,70.66,70.36,68.54,60.71,
56.35,31.62,30.37,26.91,23.97。
V-6 (1.4mmol) is dissolved in Isosorbide-5-Nitrae-dioxane (5mL), 1mL water is added, sequentially adds sodium metaperiodate
It is small to stir 12 at room temperature for (5.6mmol), 2,6- lutidines (2.8mmol) and 1 weight % osmium tetroxide aqueous solution (1mL)
When, saturated aqueous sodium thiosulfate quenching reaction is added, filters away the solid generated, ethyl acetate extraction, anhydrous slufuric acid
Magnesium is dry, filters and removes solid, removes solvent under vacuum, obtain the crude product of X-4.
Under argon gas protection, 1- bromine nonyl is added in the tetrahydrofuran of steaming again (2mL) suspension for the magnesium chips (4.2mmol) newly polished
Alkane (2.8mmol) is heated to 50 DEG C of reactions, and a large amount of bubbles occurs in system, and solution is in Dark grey, and the reaction was continued half an hour.By X-4
Crude product (in terms of 1.4mmol) be dissolved in dry tetrahydrofuran, under condition of ice bath, by above-mentioned Grignard Reagent by syringe by
It is added dropwise to, the reaction was continued 10h, TLC monitoring display raw material disappearance, addition saturated ammonium chloride solution quenching reaction, ethyl acetate extraction
It takes, without drying, directly removes solvent under vacuum, obtain the crude product of XI-4.
The crude product of gained XI-4 is redissolved in 5mL dry methylene chloride, is added triethylamine (3mmol), condition of ice bath
Under be slowly added to methylsufonyl chloride (2.4mmol), add and move back except ice bath, react at room temperature 1h, TLC monitors raw material point and disappears, adds
Entering saturated ammonium chloride quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, and it filters and removes solid, remove solvent under vacuum,
Obtain the crude product of XII-4.
The crude product of gained XII-4 is redissolved in 5mL methylene chloride, and 3mL trifluoroacetic acid is added, and after reacting 1h, TLC is shown
Raw material disappears, and saturation NaHCO is added3Quenching reaction, ethyl acetate extraction, anhydrous magnesium sulfate is dry, filters and removes solid, vacuum
Lower removing solvent, obtains the crude product of XIII-2.
The crude product of XIII-4 is redissolved in 10mL methanol, 100mg Anhydrous potassium carbonate is added, reacts at room temperature 48h, vacuum
Lower removing methanol, the thick grease of gained are redissolved in saturated ammonium chloride, and ethyl acetate extraction, anhydrous magnesium sulfate is dry,
It filters and removes solid, solvent is removed under vacuum, column chromatography (petroleum ether: ethyl acetate=15:1) obtains the lesser point of polarity
(XIV-9a) the total 261mg and total 237mg of the biggish point (XIV-9b) of polarity.Structural identification:
XIV-9a:1H NMR(400MHz,CDCl3)δ7.39–7.20(m,16H),4.83–4.37(m,6H),4.01–3.93
(m, 1H), 3.89-3.81 (m, 2H), 3.73 (q, J=6.2Hz, 1H), 3.56 (dd, J=7.2,4.9Hz, 1H), 2.57-2.47
(m, 2H), 1.95 (dd, J=16.2,6.5Hz, 1H), 1.84 (d, J=11.5Hz, 1H), 1.71 (d, J=11.0Hz, 2H),
1.37-0.92 (m, 21H), 0.88 (t, J=6.8Hz, 3H);13C NMR(101MHz,CDCl3)δ139.12,139.01,
138.80,128.50,128.44,128.40,127.98,127.75,127.67,127.62,127.53,80.71,77.92,
73.66,72.77,72.45,66.71,64.90,59.34,57.88,33.75,32.17,31.31,31.21,30.39,
29.99,29.89,29.61,25.79,24.67,22.93,14.36。
XIV-9b:1H NMR(400MHz,CDCl3)δ7.37–7.20(m,15H),4.70–4.42(m,6H),4.22(dd,J
=7.5,5.0Hz, 1H), 3.91 (dd, J=9.0,7.1Hz, 1H), 3.64 (t, J=4.5Hz, 1H), 3.52 (dd, J=9.1,
5.2Hz, 1H), 3.40-3.28 (m, 2H), 2.66 (s, 1H), 1.68-1.06 (m, 24H), 0.88 (t, J=6.7Hz, 3H);13C
NMR(101MHz,CDCl3)δ139.02,138.96,138.87,128.29,128.26,127.73,127.71,127.49,
127.42,127.34,80.62,77.64,73.32,72.86,72.06,71.86,62.90,56.82,56.22,33.05,
32.00,30.00,29.84,29.73,29.46,26.72,26.51,25.74,22.77,18.83,14.21。
Substrate XIV-9a (100mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, 0.5mL is added
3N hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, palladium carbon is filtered to remove by diatomite, under vacuum
Solvent is removed, neutralizes by ammonium hydroxide, is handled by acidic resins column, obtain the total 49mg of I-9a, colorless oil, yield 91%.
Structural identification:
1H NMR (400MHz, MeOD) δ 4.36 (t, J=7.2Hz, 1H), 3.88 (d, J=3.4Hz, 2H), 3.76 (t, J
=6.1Hz, 1H), 3.66 (d, J=3.2Hz, 1H), 2.96 (d, J=10.7Hz, 1H), 2.89 (t, J=9.4Hz, 1H), 1.97
(d, J=11.9Hz, 1H), 1.87 (dd, J=24.0,12.1Hz, 3H), 1.52-1.13 (m, 22H), 0.90 (t, J=6.5Hz,
3H);13C NMR(101MHz,MeOD)δ73.38,69.06,67.60,61.23,58.57,56.59,32.70,31.66,
29.49,29.31,29.28,29.04,28.09,25.41,23.12,22.33,13.06。
Substrate XIV-9b (100mg) is dissolved in 10mL methanol, the palladium carbon of the 10 weight % of 30mg is added, 0.5mL is added
3N hydrochloric acid, hydrogen displacement, overnight, TLC shows that raw material disappears for room temperature reaction, palladium carbon is filtered to remove by diatomite, under vacuum
Solvent is removed, neutralizes by ammonium hydroxide, is handled by acidic resins column, obtain the total 45mg of faint yellow solid I-9b, yield 97%.
1H NMR (400MHz, MeOD) δ 4.48 (s, 1H), 4.27-4.14 (m, 1H), 3.88 (s, 3H), 3.62 (d, J=
6.6Hz, 1H), 3.23-3.14 (m, 1H), 2.07-1.93 (m, 2H), 1.86 (dd, J=9.9,5.0Hz, 2H), 1.76-1.46
(m, 5H), 1.31 (s, 16H), 0.90 (t, J=6.6Hz, 3H);13C NMR(101MHz,MeOD)δ70.04,68.58,68.35,
61.12,60.53,57.75,31.64,30.92,29.23,29.19,29.16,29.02,25.82,25.35,22.33,
21.77,16.22,13.05。
Test case: the glycosidase inhibitory effect evaluation of Indolizidine class amino sugar compounds
1) test material and source
Test compound: 5 gained heptatomic ring imino sugar compounds of embodiment 4 and embodiment.
Test material: all 4- nitrophenols pyranoside matrix, disaccharides and glycosidase are purchased from Sigma-Aldrich.
2) test method
Dynamics research carries out in 37 DEG C of 50mM sodium citrate/phosphate buffer.According to the difference of matrix, preparation
Enzyme concentration is 0.1-0.5mg/mL.Active testing is using 4- nitrophenols pyranoside as matrix, in the optimum activity pH value of every kind of enzyme
Under tested.Matrix, appropriate diluted enzyme solutions and inhibitor (heptatomic ring iminosugar) are cultivated 30 minutes at 37 DEG C,
Then start reaction in ultraviolet-uisible spectrophotometer, measure its absorption to 400nm wavelength light.Finally use GraFit journey
Sequence carries out data analysis [Leatherbarrow, R.J.Grafit 4.0;Erithacus Software:Staines,UK,
1998.]。
3) evaluation result
The results are shown in Table 1 for inhibitory activity of the heptatomic ring imino sugar compounds obtained by embodiment 1-9 to glycosidase.
Evaluation result shows bicyclic class amino sugar I-2a provided by the present invention to beta galactosidase and saccharogenic amylase
There are weak inhibitory activity, IC50Respectively 796 μM and 241 μM;1-4b is to beta-glucosidase (beef liver) and beta galactosidase (ox
Liver) there are weak inhibitory activity, IC50Respectively 469 μM and 250 μM.Iminosugar I-6a, I-6b, I-7a, I-7b, I-8a, I-8b,
I-9a and I-9b has alpha-L-Rhamnosidase weak to medium inhibitory activity, IC50As shown in table 2, comprehensive analysis inhibits to live
Property seems related with long alkyl chains.
Table 1: inhibitory activity IC of the part Indolizidine class imino sugar compounds to glycosidase50(μM)
Glycosidase | I-1a | I-1b | I-2a | I-3a | I-3b | I-4b | I-5a | I-5b |
Alpha-glucosidase | ||||||||
Yeasta | b(8.1%) | (28.1%) | (0.7%) | (5.0%) | (4.4%) | (5.0%) | (6.7%) | (0.6%) |
Rice | (44.5%) | (33.8%) | (5.7%) | (2.6%) | (0%) | 933 | (42.7%) | (5.0%) |
Rat small intestine maltose | 351 | 562 | (7.2%) | (20.9%) | (0.5%) | (39.2%) | (41.7%) | (10.3%) |
Rat small intestine isomaltase | (37.2%) | 870 | (11.6%) | (11.6%) | (4.9%) | (4.5%) | (17.1%) | (14.8%) |
Rat small intestine invertase | 173 | 111 | (7.7%) | (6.9%) | (16.5%) | 795 | (24.5%) | (0.7%) |
Beta-glucosidase | ||||||||
Almond | (0%) | (0%) | (16.8%) | (0%) | (0%) | (26.7%) | (10.8%) | (0.7%) |
Beef liver | (25.1%) | (14.2%) | (35.7%) | (17.6%) | (6.6%) | 469 | (2.0%) | (14.5%) |
Alpha-galactosidase | ||||||||
Coffee bean | (12.1%) | (4.7%) | (5.3%) | (2.6%) | (5.8%) | (36.4%) | (0%) | (0%) |
Beta galactosidase | ||||||||
Beef liver | (25.2%) | (13.2%) | 796 | (13.2%) | (8.5%) | 250 | (31.1%) | (38.9%) |
Alpha-Mannosidase | ||||||||
Sword bean | (0%) | (0.6%) | (0%) | (0%) | (7.9%) | (28.9%) | (13.9%) | (18.5%) |
Beta-Mannosidase | ||||||||
Snail | (9.1%) | (1.0%) | (0%) | (4.3%) | (1.2%) | (0%) | (0%) | (1.6%) |
Alpha-L-fucosidase | ||||||||
Ox kidney | (4.3%) | (0%) | (0%) | (9.1%) | (0%) | (4.3%) | (3.3%) | (0%) |
A, a-trehalose enzyme | ||||||||
Pig kidney | (0%) | (0%) | (0.3%) | (0%) | (3.3%) | (3.5%) | (6.6%) | (2.1%) |
Saccharogenic amylase | ||||||||
Aspergillus niger | (3.3%) | (0%) | 241 | (0%) | (0%) | (2.1%) | (21.1%) | (7.2%) |
Alpha-L-Rhamnosidase | ||||||||
Penicillium decumbens | (42.6%) | 415 | (0%) | (15.9%) | (3.4%) | 722 | (22.2%) | (0%) |
GRD beta-glucuronidase | ||||||||
Escherichia coli | (19.9%) | 43.9%) | (5.8%) | (5.9%) | (2.6%) | (42.5%) | (22.5%) | (27.9%) |
Beef liver | (4.4%) | (0%) | (4.3%) | (5.5%) | (3.8%) | (9.9%) | (10.5%) | (0.9%) |
aThe source of enzyme;b(): the inhibiting rate under 1000 μM of concentration.
Table 2
It can be seen from the results above that the Indolizidine iminosugar of offer of the invention or its is pharmaceutically acceptable
Salt has the activity for inhibiting glycosidase and can be used in treating diabetes.Moreover, Indolizidine imino group provided by the invention
The precursor compound of sugar also has the active effect for inhibiting glycosidase.
The preferred embodiment of the present invention has been described above in detail, still, during present invention is not limited to the embodiments described above
Detail within the scope of the technical concept of the present invention can be with various simple variants of the technical solution of the present invention are made, this
A little simple variants all belong to the scope of protection of the present invention.
It is further to note that specific technical features described in the above specific embodiments, in not lance
In the case where shield, can be combined in any appropriate way, in order to avoid unnecessary repetition, the present invention to it is various can
No further explanation will be given for the combination of energy.
In addition, various embodiments of the present invention can be combined randomly, as long as it is without prejudice to originally
The thought of invention, it should also be regarded as the disclosure of the present invention.
Claims (7)
1. a kind of Indolizidine iminosugar, the iminosugar is in following compound or its pharmaceutically acceptable salt
At least one:
2. a kind of method for preparing iminosugar described in claim 1, this method comprises: in acid condition, being deposited in catalyst
Under, the precursor compound of the iminosugar is subjected to hydrogenation;Or
In the presence of a lewis acid, the precursor compound of the iminosugar is subjected to deprotection reaction;
The precursor compound is the compound or its pharmaceutically acceptable salt of structure shown in XIV:
3. according to the method described in claim 2, wherein, the catalyst is selected from palladium carbon, palladium black, palladium dydroxide, palladium chloride, oxygen
Change at least one of platinum, platinum black, ruthenic chloride and Wilkinson catalyst.
4. according to the method described in claim 2, wherein, the precursor compound is structure shown in Formula XIV -6a and XIV-6b
The preparation method of compound or its pharmaceutically acceptable salt, comprising the following steps:
Alternatively, the precursor compound is the compound or its pharmaceutically acceptable salt of structure shown in Formula XIV -7a and XIV-7b
Preparation method, comprising the following steps:
Alternatively, the precursor compound is the compound or its pharmaceutically acceptable salt of structure shown in Formula XIV -8a and XIV-8b
Preparation method, comprising the following steps:
Alternatively, the precursor compound is the compound or its pharmaceutically acceptable salt of structure shown in Formula XIV -9a and XIV-9b
Preparation method, comprising the following steps:
In formula, a is to be reacted with Grignard Reagent, and b is reduction reaction, and c is that protection reaction is carried out under alkaline condition, and d is oxidation
Reaction, e are to be reacted with Grignard Reagent, and f is sulfonating reaction, and g is deprotection reaction, and h is ring closure reaction.
5. iminosugar described in claim 1 or its pharmaceutically acceptable salt are in the drug that preparation inhibits glycosidase activity
Application.
6. application according to claim 5, wherein the glycosidase is selected from alpha-glucosidase, beta-glucosidase, α-
Galactosidase, beta galactosidase, alpha-Mannosidase, beta-Mannosidase, alpha-L-fucosidase, trehalase, shallow lake
At least one of powder glucuroide and alpha-L-Rhamnosidase.
7. iminosugar described in claim 1 or its pharmaceutically acceptable salt preparation prevention and/or treatment diabetes,
Application in prevention and/or treatment gaucher's disease, prevention and/or treatment tumour and antiviral drug.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610202477.7A CN105732620B (en) | 2016-04-01 | 2016-04-01 | Indolizidine iminosugar and its precursor compound and their preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610202477.7A CN105732620B (en) | 2016-04-01 | 2016-04-01 | Indolizidine iminosugar and its precursor compound and their preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105732620A CN105732620A (en) | 2016-07-06 |
CN105732620B true CN105732620B (en) | 2018-12-11 |
Family
ID=56253499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610202477.7A Active CN105732620B (en) | 2016-04-01 | 2016-04-01 | Indolizidine iminosugar and its precursor compound and their preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105732620B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106966943B (en) * | 2017-03-24 | 2020-09-18 | 中国科学院化学研究所 | C4 branched polyhydroxy pyrrolidine compound and preparation method and application thereof |
CN112142732B (en) * | 2020-10-06 | 2021-09-24 | 大连理工大学 | Preparation method of chiral indolizidine compound |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105085356A (en) * | 2015-08-26 | 2015-11-25 | 中国科学院化学研究所 | Broussonetia kazinoki alkaline compound and preparation method and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110237538A1 (en) * | 2008-08-06 | 2011-09-29 | Summit Corporation Plc | Treatment of lysosomal storage disorders and other proteostatic diseases |
-
2016
- 2016-04-01 CN CN201610202477.7A patent/CN105732620B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105085356A (en) * | 2015-08-26 | 2015-11-25 | 中国科学院化学研究所 | Broussonetia kazinoki alkaline compound and preparation method and application thereof |
Non-Patent Citations (2)
Title |
---|
《A Glycal Approach to the Synthesis of Steviamine Analogues Venkatesan Santhanam and Namakkal G. Ramesh》;Venkatesan Santhanam, et al;《Eur.J.Org.Chem.》;20141231;第2014卷(第31期);第6992-6999页 * |
Jia Shao et al..《A Diastereoselective Cyclic Imine Cycloaddition Strategy To Access Polyhydroxylated Indolizidine Skeleton: Concise Syntheses of (+)-/(−)-Lentiginosines and (−)-2-epi-Steviamine》.《The Journal of Organic Chemistry》.2012,第77卷(第18期),第7891−7900页. * |
Also Published As
Publication number | Publication date |
---|---|
CN105732620A (en) | 2016-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tsou et al. | A convenient approach toward the synthesis of enantiopure isomers of DMDP and ADMDP | |
TW201748B (en) | ||
EP1851214B1 (en) | Isoxazoline derivative and novel process for its preparation | |
RU2553476C2 (en) | Method of synthesising e1-activating enzyme inhibitors | |
NO890567L (en) | Anthracycline-DERIVATIVES. | |
CN105732620B (en) | Indolizidine iminosugar and its precursor compound and their preparation method and application | |
Izquierdo et al. | Total synthesis of natural (+)-hyacinthacine A6 and non-natural (+)-7a-epi-hyacinthacine A1 and (+)-5, 7a-diepi-hyacinthacine A6 | |
EP3563851B1 (en) | Antitumor agent and bromodomain inhibitor | |
Zoidl et al. | The Staudinger/aza-Wittig/Grignard reaction as key step for the concise synthesis of 1-C-Alkyl-iminoalditol glycomimetics | |
Kalamkar et al. | Concise and practical route to tri-and tetra-hydroxy seven-membered iminocyclitols as glycosidase inhibitors from d-(+)-glucurono-γ-lactone | |
NO300686B1 (en) | Analogous Process for the Preparation of Therapeutically Active 6-Aminoctahydroindolizine Triol Derivatives | |
CN105198829B (en) | A kind of Preparation Method And Their Intermediate and purposes than his intermediate of department | |
CN110128315A (en) | Compound and the preparation method and application thereof, glycosidase inhibitor | |
CN106278928B (en) | A kind of synthetic method of Oseltamivir phosphate isomer impurities | |
CN105541854B (en) | Preparation method and spherosin derivative of spherosin and its intermediate and its preparation method and application | |
CN105330590B (en) | The preparation method of sitafloxacin five-membered ring side chain intermediate | |
Gupta et al. | (3S, 4R, 5R)-3-(2-Hydroxyethyl) piperidine-3, 4, 5-triol as an isofagomine analogue: synthesis and glycosidase inhibition study | |
Leeuwenburgh et al. | A Short and Flexible Route to Aza‐β‐(1→ 6)‐C‐disaccharides: Selective α‐Glycosidase Inhibitors | |
US7534811B2 (en) | Cyclic onium compounds and glucosidase inhibitors | |
Park et al. | Synthesis and evaluation of ent-Conduramine C-1 derivatives as α-glucosidase inhibitors via CSI-mediated amination reaction | |
CN107814790A (en) | Topsentin analog derivatives and its preparation and the application in Antiphytoviral and germ | |
JP2006131587A (en) | Tyrosine glycoside, method for producing the same and use thereof | |
Elečko et al. | Synthesis of 5-amino-α-D-gluco-hept-6-enfuranose as usefull 1-deoxynojirimycin precursor using [3, 3]-sigmatropic aza-Claisen rearrangement | |
PUNGOT et al. | Synthesis of 3-methyl-5-nitrobenzyl β, β-diketoester as a derivative of pachydermin, a tetramic acid from Chamonixia pachydermis | |
Key et al. | Unusual Transacetylation in 3, 4-Difunctionalized Pyrrolidine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |